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ABSTRACT
Staphylococcus lugdunensis is an opportunistic pathogen that can cause invasive infections
suggesting an ability to circumvent host immunity. S. lugdunensis was shown to resist
killing and persist within macrophages and acetylation of its peptidoglycan is important for
this survival. This was consistent in vivo, as S. lugdunensis resides inside Kupffer cells for
at least 16 hours post-infection in mice. Despite its capability for survival, S. lugdunensis
is unable to replicate within phagolysosomes. Inhibiting phagolysosomal effectors allows
S. lugdunensis to initiate replication, after which the bacteria escape phagosomal
containment. Moreover, intracellular S. lugdunensis augments the growth S. aureus during
co-infection. Eight hours following secondary infection of S. lugdunensis-infected mice
with S. aureus, the S. aureus burden in the liver is amplified 10-fold above mice infected
with S. aureus alone. It was found that the macrophage represents an undescribed reservoir
for viable S. lugdunensis that can potentiate the virulence of S. aureus.
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CHAPTER 1 – LITERATURE REVIEW
1.1 Introduction to innate immunity
Innate immunity is the first line of defense against the invasion of pathogens
providing immediate, yet non-specific and relatively short-lived defense against infection.
There are multiple components to innate immunity including physical/chemical barriers,
the complement system, and phagocytic immune cells, that help prevent the invasion and
spread of foreign microbes (1–3). Microbes are ubiquitous throughout the gastrointestinal
tract and on the human skin, yet these bacteria rarely cause infection. Epithelial cells lining
the skin, respiratory, gastrointestinal, urogenital tracts provide a physical barrier, which
microbes are unable to cross. In addition to the physical barrier these environments also
produce several chemical barriers, such as the low pH of the upper gastrointestinal tract.
Moreover, human skin has a high amount of salt and fatty acids, which prevent the growth
of many bacteria (4,5). However, when these barriers are breached by some means,
pathogens will be able to bypass the physical and chemical barriers allowing them to invade
into the host tissues. Additionally, many host tissues have another barrier to infection,
known as colonization resistance, whereby commensal bacteria colonizing the host will
compete with pathogens for nutrients and attachment sites (6,7).
If pathogens are able to circumvent the initial barriers, they may then be faced with
the humoral component of innate immunity including the complement system. The
complement system consists of small soluble proteins produced in the liver and by a variety
of immune cells. When activated the complement system results in the cleavage of C3 into
C3a and C3b, the latter of which is deposited on the surface of pathogens (3). The
deposition of C3b initiates a proteolytic cascade resulting in the formation of the membrane
attack complex (MAC). The MAC forms transmembrane channels leading to osmotic lysis
of the hosts cells (8). Furthermore, C3b functions as an opsonin leading to increased uptake
of bacteria by phagocytic cells such as dendritic cells or macrophages (9). Although it is a
critical component of innate immunity, the complement system was originally named for
being exactly that – a complement to the phagocytic cells protecting against foreign
microbes.
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1.2 Phagocytes
Phagocytes are specialized immune cells that employ the receptor-mediated process
of phagocytosis to prevent the invasion and spread of microbes past the initial site of
infection. There are several cell types that can be classed as phagocytes including
neutrophils, dendritic cells and macrophages. Macrophages are the major phagocytic cell
type that will be focused on throughout this project. The mechanisms by which phagocytes
contribute to innate immunity will be reviewed further in the following sections.
1.2.1 Macrophages
Macrophages are specialized tissue-resident phagocytes that participate in the
eradication of invading microbes. Monocytes, the precursor to recruited macrophages, are
initially found in circulation, but during inflammation chemoattractant molecules, known
as chemokines, are produced to recruit monocytes to the inflamed tissues (10). CCL2 is a
major ligand expressed by endothelial cells in response to pro-inflammatory cytokines.
This ligand will then bind to CCR2 which is found on monocytes, mediating
chemoattraction (10,11). After chemoattraction the monocytes must migrate from
circulation to the inflamed tissue. To accomplish this, monocytes are thought to follow the
same process of leukocyte extravasation. In this process the cells in circulation bind to
selectins in the blood vessel to begin rolling adhesion, then bind to integrins mediating tight
adhesion, and lastly cytoskeletal rearrangements allow the cells to transmigrate out of the
vessel into tissue (10). Once in the inflamed tissue, the monocytes are differentiated into
macrophages. These macrophages can take on different phenotypes based on the
combination of cytokines present in the surrounding environment at the time of
differentiation. These phenotypes fall on a spectrum of polarization states, on the one end
the classically-activated M1 polarized macrophages, which are typically induced by the
presence of pathogen-associated molecular patterns (PAMPs) along with inflammatory
cytokines (IFN-g) exhibit enhanced microbicidal activity (12). On the opposite end of the
polarization spectrum, the alternatively-activated M2 macrophages, induced by antiinflammatory cytokines (IL-10 and IL-4), and play a role in tissue remodelling and repair
more so than infection control (12,13).
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Macrophages are critically important immune cells as they not only play a role in
innate immunity but also contribute to the adaptive immune response. Macrophages
possess a wide array of surface pattern recognition receptors (PRRs), which recognize and
bind to conserved PAMPs allowing them to recognize and respond to an assortment of
invading pathogens. In addition to the cell surface receptors macrophages are constantly
reaching out and surveying the surrounding environment for signs of a threat using
cytoplasmic extensions known as filopodia to engage foreign particles (14). This allows
macrophages to effectively seek out and bind any foreign microbes that might pose a threat
to the host, which will then be phagocytosed.
1.2.2

Phagocytosis
To prevent the spread of invading pathogens macrophages use the receptor-

mediated process of phagocytosis to internalize large particles into a membrane-bound
compartment known as a phagosome (15). This process is initiated when foreign microbes
or other particles engage receptors on the macrophage cell surface. Macrophages express
a wide variety of PRRs such as Fcg receptors which recognize the Fc portion of human IgG
antibodies on opsonized particles (16), or scavenger receptor A, which binds to lipoteichoic
acid or lipopolysaccharide (LPS) (17). After the phagocytic receptor is engaged additional
receptors will cluster around the bound ligand to activate signal transduction events leading
to the initiation of internalization. FcgR-mediated uptake is the best understood model of
phagocytosis, whereby clustering of receptors results in the cytosolic immunoreceptor
tyrosine-based activating motif (ITAM) domains being phosphorylated (16). This
phosphorylation initiates downstream signaling events causing rearrangement of the actin
cytoskeleton and membrane fusion resulting in the foreign particle being internalized into
the membrane-bound nascent phagosome (16,18). Phagocytosis is a rapid process taking
only seconds to a few minutes from engagement of the phagocytic receptor to uptake of
the microbe. This enables phagocytes play a critical role in the restriction of invading
microbes, although phagocytosis in and of itself is not a microbicidal process.
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1.2.3 Phagosome maturation
Immediately after uptake, microbes will be contained within the nascent
phagosome, which is a relatively innocuous environment with the membrane resembling
the plasma membrane from which it was derived, and the lumen will be reflective of the
extracellular environment at the time of uptake, making it insufficient for particle
destruction (15). In order to degrade and eliminate engulfed particles the phagosome is
rapidly trafficked through a maturation process resulting in the formation of a highly
degradative and microbicidal compartment known as the phagolysosome (19). Phagosome
maturation consists of several controlled membrane fusion and fission events resulting in
significant biochemical changes to both the membrane and lumen of the phagosome.
Importantly, each stage of phagosome maturation can be defined based on the membrane
composition, which is altered by these fusion and fission events.
The first major event in phagosome maturation is the accumulation of Rab5 in the
phagosomal membrane, which facilitates fusion of the nascent phagosome with early
endosomes (20) to form the early phagosome. Additionally, the phagosome acquires
Vps34, a phosphatidylinositol-3 kinase (PI3K), which converts phosphatidylinositol to
phosphatidylinositol-3-phosphate [PI(3)P], a key lipid involved in the maturation process
(21). The early phagosome will then continue the maturation process in order to transition
into a late phagosome. In this transition Rab5 is lost coinciding with the acquisition of Rab7
and generation of phosphatidylinositol-4-phosphate [PI(4)P] in the phagosomal membrane
(20,22). Additionally, the late phagosome can be characterized by the presence of the
lysosomal associated membrane protein 1 (LAMP-1), which is an integral membrane
protein typically found in the membranes of late endosomes and lysosomes (23). The exact
role of LAMP-1 in the maturation process remains unclear, although it is known that
Neisseria gonorrhoeae is able to specifically degrade LAMP-1 to promote its intracellular
survival, clearly implicating LAMP-1 as an essential factor for restriction (24). Rab7 plays
a critical role in maturation as it is responsible for recruiting several effector proteins
including Rab7-interacting lysosomal protein (RILP) and oxysterol-binding protein–
related protein 1 (ORPL1), which coordinate the trafficking and fusion of lysosomes with
the late-phagosome (25,26). The fully mature phagolysosome is biochemically defined by
the presence of LAMP-1 in the membrane, along with the presence of lysosomal hydrolases
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and a highly acidic lumen (1,15,27). The phagolysosome is the end result of a carefully
controlled maturation process and is the ultimate microbicidal organelle in the cell.
1.2.4 Antimicrobial effectors of the phagolysosome
Foreign particles or microbes will be engaged and taken up by macrophages into a
nascent phagosome, which is initially innocuous but rapidly matures to become a highly
microbicidal compartment. The mature phagolysosome employs a variety of restrictive
and degradative mechanisms including, but not limited to, low pH, nutrient limitation,
digestive enzymes, and reactive oxygen species (ROS) (1). These effectors function to
restrict and eliminate microbes contained within the compartment.
In order to acidify the phagosome vacuolar-ATPases work to pump protons into the
lumen of the phagosome, which accumulate over time, decreasing the pH of the
compartment (28). Importantly, maturing phagosomes have reduced passive proton
permeability, preventing proton leakage and thereby allowing for continued acidification
throughout maturation (28). This allows the pH of the phagosome to decrease from ~7 to
4.5 over the course of the maturation process. The decreased pH of the phagolysosome can
directly restrict the growth of many bacteria, but also functions in concert with NADPH
oxidase to produce ROS to further damage the luminal contents (1,29). Furthermore,
several digestive enzymes such as the proteolytic cathepsins or the hydrolytic lysozyme
are delivered to the phagosomal lumen throughout the maturation process. These enzymes
function to kill and degrade any contained microbes and notably many of these enzymes
exhibit optimal activity under the low pH conditions of the mature phagolysosome (30,31).
Macrophages also employ antimicrobial mechanisms such as nutrient limitation,
which is a restrictive but not degradative process. Nutritional immunity is a process
whereby the host sequesters essential nutrients making them inaccessible to invading
microbes hindering their growth and virulence (32). A key effector of nutritional immunity
in macrophages is the natural resistance-associated macrophage protein 1 (NRAMP1),
which gets recruited to phagosomal membranes during infection (33,34). NRAMP1
functions to actively pump divalent cations (Mn2+, Zn2+, and Fe2+) out of the phagosomal
lumen making them inaccessible to the phagocytosed bacteria (35,36). These nutrients are
essential for several bacterial processes and their exclusion limits the growth and virulence
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of many bacterial species. The growth-arrested bacteria are then killed by the array of
microbicidal effectors previously described allowing for effective elimination of the
phagosomal contents.
1.2.5 Mechanisms pathogens use to overcome macrophages
Macrophages are an important part of the initial response to invading microbes, but
in the case of disease the causative pathogens clearly have adapted to survive when
challenged by these phagocytic cells. In order to overcome macrophages, pathogens have
acquired a variety of mechanisms allowing them to survive or circumvent the antimicrobial
effectors previously discussed. These strategies can differ widely from surviving in the
phagolysosome, preventing maturation to a phagolysosome, or escaping the phagosome
entirely. Regardless of the mechanism of action, to cause disease a pathogen must be able
to overcome the initial challenge by host macrophages.
Mycobacterium tuberculosis is a widespread pathogen that is well-known for its
ability to survive within host macrophages, by blocking the maturation of M. tuberculosis
containing phagosomes. M. tuberculosis is contained in Rab5-positive early phagosomes
but inhibits the recruitment of Rab5 effectors such as Vps34, which prevents the
accumulation of PI(3)P (1,37). The lack of PI(3)P accumulation on the early phagosomes
prevents maturation to late and phagolysosomal stages (38), providing an environment
much more conducive to the growth and survival of M. tuberculosis. In contrast to M.
tuberculosis, which modifies the phagosome to make it more habitable, Listeria
monocytogenes is able to altogether escape phagosomal containment, while remaining
within the macrophages allowing for its survival (1,39). In order to escape phagosomal
containment, L. monocytogenes encodes listeriolysin O (LLO), a pore forming toxin, and
two distinct phospholipase C enzymes, allowing for dissolution of cellular membranes and
escape from the phagosomal compartment (40,41). Furthermore, some pathogens such as
Staphylococcus or Streptococcus species encode specialized machinery that allow for
enhanced survival within mature phagolysosomes (42,43).
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1.3 Staphylococcus aureus
S. aureus is a Gram-positive facultative anaerobe found persistently colonizing the
nose of roughly 30% of the human population. It is also a major cause of skin and soft
tissue infections, sepsis, and osteomyelitis (44). The success of S. aureus as a major human
pathogen is largely due to its extensive arsenal of virulence factors that enable S. aureus to
colonize and infect virtually every tissue in the human body. In addition to numerous
toxins, S. aureus encodes several factors enabling it to resist immune attack promoting
enhanced survival within the host. Furthermore, S. aureus has also developed resistance to
several types of antibiotics complicating treatment and ultimately leading to the evolution
of methicillin-resistant S. aureus (MRSA). In the 1990s invasive MRSA emerged within
the community setting with the strain USA300 in particular reaching pandemic status
across North America. Infections caused by invasive MRSA come with approximately a
20% mortality rate making it the leading cause of death by an infectious agent in the United
States (45,46). S. aureus is a major burden on the healthcare system and the lack of an
effective vaccine for this species is a significant concern, underscoring the need for
continued investigation into the pathogenic mechanisms of S. aureus.
1.3.1 S. aureus virulence factors
S. aureus is a prolific pathogen that can infect virtually any part of the human body
owing to its arsenal of virulence factors. These virulence factors serve a variety of purposes
from immune evasion to leukocyte killing and antimicrobial resistance to promote bacteria
survival and spread. S. aureus is able to carefully regulate the production of its virulence
factors, initially employing factors for immune evasion and survival in order to adapt to
and colonize different tissues. After colonization, S. aureus can proliferate, and initiate
toxin production allowing for invasion and spread past the initial site of infection and
eventually to a new host.
A key virulence factor allowing for immune evasion is protein A, which is able to
non-specifically bind the Fc region of IgG antibodies (47). By binding antibodies in the
reverse direction, protein A provides a protective coat on the surface of S. aureus
preventing opsonization and uptake by phagocytes (48). Additionally, by blocking
antibody-mediated responses, protein A contributes to the ability of S. aureus to re-infect
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the same host (49). S. aureus also encodes multiple cell wall modification systems allowing
for resistance to immune effectors such as lysozyme and cationic antimicrobial peptides
(CAMPs), to promote bacterial survival. The dltABCD encodes enzymes that function to
esterify D-alanine to the teichoic acids thereby contributing to a net positive charge of the
cell wall (50,51). The increased charge helps to repel CAMPs such as cathelicidins, which
normally bind to the bacterial surface and insert into the membrane, killing the cell (52).
The oatA enzyme is another cell wall modifying enzyme encoded by S. aureus. OatA
functions to O-link an acetyl group to the N-acetylmuramic acid of the peptidoglycan (53).
This acetate sterically hinders lysozyme, preventing it from binding and hydrolyzing the
glycosidic bonds in the peptidoglycan (54). These modification systems are important for
the ability of S. aureus to survive both intra- and extracellularly during an infection (55).
After colonizing host tissues S. aureus will initiate toxin production through the
accessory gene regulator (agr) quorum sensing system, which is a global regulator of toxin
production (56). S. aureus can produce several cytolytic toxins in order to combat immune
cells leading to inflammation and tissue damage. The alpha-, beta-, and delta toxins along
with the bi-component leukocidins are some of the major hemolytic and cytolytic toxins
that promote severe infections by S. aureus. The a-toxin, also known as a-hemolysin, has
a b-barrel structure allowing it to insert into and form pores in cellular membranes leading
to apoptosis (57). The b-toxin functions as a sphingomyelinase making it toxic to cells such
as erythrocytes, fibroblasts, and macrophages, which have sphingomyelin exposed at the
cell surface (58). The d-toxin produced by S. aureus is part of the phenol soluble modulin
peptide family with an alpha helical amphipathic structure (59). This structure allows the
d-toxin to function similar to a detergent where it is able to non-specifically insert into and
disrupt cellular membranes resulting in cell lysis (59). The bi-component leukocidins are
thought to be important for targeting and lysing immune cells including neutrophils and
macrophages (60,61). Each polypeptide of these bi-component toxins binds to the cell
surface as a monomer before coming together and oligomerizing to form an octameric
transmembrane b-barrel pore lysing the cell (62). These toxins are carefully regulated to
work in concert with several other virulence determinants produced by S. aureus to help
the bacteria to overwhelm or otherwise circumvent the hosts immune response and cause
tissue damage contributing to productive infection allowing for bacterial spread.
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1.3.2 Interactions between S. aureus and macrophages
While S. aureus has been traditionally thought of as an extracellular pathogen, it
has become abundantly clear that S. aureus is also able to successfully occupy an
intracellular niche within multiple cell types (63–65). Specifically, S. aureus has become
well known for its ability to survive internalization and take up residence within
professional phagocytes including macrophages (42,66). S. aureus is known to survive
intracellularly within both murine and human macrophages in vitro for extended periods
of time. Furthermore, infected macrophages maintained in the presence of extracellular
antibiotics were able to contain S. aureus for much longer than those without antibiotics,
despite the antibiotic being membrane-impermeant (42,65). Although the mechanism by
which extracellular antibiotic can restrict intracellular S. aureus has not been characterized,
presumably the host cell would uptake antibiotic through pinocytosis resulting in delivery
of antibiotic to the S. aureus containing phagosome. Moreover, extracellular antibiotic
would immediately kill any bacteria emerging from host cells, thereby preventing
intoxication by extracellular S. aureus. It is worth noting that fluorescence microscopy has
been used to confirm that S. aureus in fact resides within fully mature phagolysosomes in
vitro without succumbing to the plethora of microbicidal effectors in these compartments
(42,67,27). The ability of S. aureus to survive within macrophages is consistent in vivo, as
S. aureus has been shown to be taken up by specialized liver-resident macrophages called
Kupffer cells within minutes of intravenous injection of bacteria in mice (68). S. aureus is
capable of readily proliferating within macrophages both in vitro and in vivo eventually
leading to host cell death and release of the bacteria, which can then disseminate resulting
in further infection.
1.4 Staphylococcus lugdunensis
S. lugdunensis is an opportunistic pathogen that behaves similarly to S. aureus both
in the lab and clinically and will be the main species of focus in this work. S. lugdunensis
is a Gram-positive, facultative anaerobe that asymptomatically colonizes human skin,
predominantly on the lower half of the body, although some strains are also known to
colonize the nasal cavity (69). One key difference between S. aureus and S. lugdunensis is
that S. lugdunensis lacks a secreted clotting factor and is therefore classed as a coagulase
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negative species (CoNS). However, it should be noted that some strains of S. lugdunensis
have been found to possess a membrane-bound clotting factor, which can cause it to
occasionally test positive in the rapid coagulase tests that are frequently used in many
clinical settings (70). Furthermore, S. lugdunensis is known to cause a variety of skin and
soft tissue infections very similar to those caused by S. aureus including, but not limited
to, abscesses, wound infections, osteomyelitis, and endocarditis (71–73). This makes it
understandable that S. lugdunensis infections are occasionally misdiagnosed as S. aureus
(74), leading to an underestimation of the true burden of S. lugdunensis infections.
Although S. lugdunensis remains a less frequent cause of infection than S. aureus, the
infections caused by S. lugdunensis have the potential to be highly invasive and lethal,
closely resembling infections caused by S. aureus (70). Furthermore, S. lugdunensis is
slowly becoming resistant to clinically relevant antibiotics which will lead to increased
difficulties in treating infections caused by this species (75–77).
Despite the fact that S. lugdunensis was first isolated in 1988, it only recently has
begun to gain notoriety as a significant pathogen with the capability to cause serious
infection (78). Recent improvements in diagnostics through increased implementation of
mass spectrometry based diagnostic methods for bacterial identification has enhanced the
detection of S. lugdunensis in clinical samples (76,79). As more clinics adopt mass
spectrometry-based methods the true burden of S. lugdunensis infections will be revealed
(76). Due to the fact that S. lugdunensis has been an underappreciated pathogen,
remarkably few virulence factors have been identified or characterized at this point in time.
The following section will discuss some of the known virulence factors and pathogenic
mechanisms of S. lugdunensis.
1.4.1 S. lugdunensis virulence factors
Currently only a few of S. lugdunensis’ virulence factors have been characterized,
however, those virulence factors that have been characterized are known contribute to its
ability to cause invasive infections. It is worth noting that many of the virulence factors
encoded by S. lugdunensis are very similar to those found in S. aureus, however, S.
lugdunensis lacks many of the toxins produced by S aureus (80). Similar to S. aureus, S.
lugdunensis employs multiple cell wall modification systems in order to resist host
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defenses. Importantly, S. lugdunensis encodes both oatA and the dlt operon described
previously, thereby conferring resistance to lysozyme and CAMPs respectively (55,81).
Additionally, S. lugdunensis possesses multiple adhesion proteins allowing effective
colonization of host tissues. Two of the major adhesion proteins utilized by S. lugdunensis
are the von Willebrand factor binding protein (vWbl) and fibrinogen-binding protein (fbl)
(82,83). As its name suggests vWbl binds to von Willebrand factor (vWf), a glycoprotein
found on platelets and cells (84). Normally vWf allows for coagulation following vascular
injury (84), but when the vasculature becomes damaged during an infection vWf can be
exploited by S. lugdunensis allowing for adhesion. Furthermore, the fbl produced by S.
lugdunensis is structurally and functionally similar to clumping-factor A produced by S.
aureus, which binds to host fibrinogen, a major plasma protein and component of the
extracellular matrix (85,86). Binding to fibrinogen allows S. lugdunensis to adhere to a
wide variety of host tissues and is important for the initiation of biofilm formation (87).
Moreover, the expression of multiple adhesins could conceivably be linked to the enhanced
ability of S. lugdunensis to infect human heart valves.
The expression of virulence factors is a carefully regulated process and after
effectively colonizing host tissues S. lugdunensis must then initiate toxin production to
cause tissue damage allowing for spread passed the initial site of infection. Despite lacking
many of the secreted toxins encoded by S. aureus, S. lugdunensis retains the ability to
invade deep into host tissues causing severe infections. Importantly, S. lugdunensis is
known to encode three S. lugdunensis synergistic hemolytic (SLUSH) peptides, which
together function akin to the S. aureus d-toxin, disrupting cellular membranes resulting in
host cell lysis (59,80,88). SLUSH-ABC are three highly similar peptides consisting of 43
amino acids that cause hemolysis, but there is also a hypothetical 24-amino acid peptide of
unknown function upstream of SLUSH-A (70). Furthermore, the SLUSH peptides are
known to exhibit synergistic activity with the b-toxin from S. aureus, leading to enhanced
lysis of red blood cells on sheep blood agar (88). The SLUSH peptides in addition to the
other virulence factors encoded by S. lugdunensis are tightly regulated to allow for effective
colonization of host tissues, leading to invasive infections with devastating outcomes.
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1.4.2 Antimicrobial resistance in S. lugdunensis
In contrast to S. aureus, which is well known for its status as an antibiotic resistant
superbug, S. lugdunensis has been relatively slow to gain antibiotic resistance, largely
remaining susceptible to routinely used drugs. Various studies have reported increasing
rates of penicillin resistance in clinical S. lugdunensis isolates over time starting below 4%
(89), but more recent reports found that up to 50-85% of isolates in Taiwanese hospitals
were found to be resistant to penicillin (75,90). The increase in resistance to penicillin is
concerning, but a much more worrying matter is the emergence of S. lugdunensis strains
carrying the mecA gene for methicillin resistance (75,77,91). These methicillin resistant S.
lugdunensis isolates were first detected in east Asia but have now been found on four
separate continents (74,77,91,92). Interestingly, despite the spread of S. lugdunensis strains
carrying mecA around the globe, the infections by mecA-positive S. lugdunensis strains
remains fairly rare. It is fortunate that even in the rare case of methicillin resistance all
isolates have remained sensitive to killing by vancomycin (92), although this remains a last
resort treatment and is not routinely administered. This highlights the importance of
antibiotic resistance in S. lugdunensis as resistance genes have spread globally, giving S.
lugdunensis the potential to accumulate multiple drug resistances similar to S. aureus,
further complicating treatment of invasive S. lugdunensis infections.
1.5 Microbial interactions
Microorganisms are found virtually everywhere in the world and while research
frequently focuses on the interactions between a single species and its host, individual
species are rarely found in isolation and various species frequently interact with each other
by several different mechanisms. Interspecies interactions can elicit many different
outcomes but can generally be classed as either cooperative or competitive interactions
(93,94). Competitive interactions are more common in the context of a battle between
species during colonization, whereas cooperative interactions are more relevant in the
context of mixed infections. These interactions are especially important when considering
the effect on opportunistic pathogens where the colonization, growth and virulence of each
species can be reduced or enhanced. Previously S. lugdunensis and S. aureus have been
shown to interact with each other, undergoing both competitive and cooperative
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interactions depending on the environmental context in which the species engage each
other (95,96). Furthermore, both S. aureus and S. lugdunensis isolates have each been
reported to regularly be found as part of mixed infections with an assortment of other
species (70,97), and occasionally with each other (72). The following sections will further
discuss general mechanisms and outcomes of microbial interactions, as well as specific
interactions between S. lugdunensis and S. aureus.
1.5.1 Competitive interactions
As previously mentioned, bacterial species are rarely found in isolation and are
usually found as part of a much larger polymicrobial community. Within this community
each species must compete with the others to establish its own niche. In this competition
microbes will employ both offensive and defensive factors in an ongoing battle for
colonization. One mechanism of competition is through the use of secreted factors to
interrupt normal signaling events of neighbouring species, perturbing downstream
processes potentially required for growth or virulence. Another common mechanism used
by bacteria to outcompete other species is to produce specialized metabolites that function
as antibiotics to directly kill off other microbes in the local environment (98). Streptomyces
species are well known for their production of specialized metabolites that function as
antibiotics, producing over two-thirds of clinically-relevant antibiotics (99,100).
Importantly, species that produce antimicrobial metabolites must also encode resistance
mechanisms to avoid self-killing by these metabolites. This serves as a reminder that
competition is not only about offense, as successful competitors must also employ
resistance factors to survive attack from other species. Bacterial species that are better
competitors will be much more effective colonizers and can possibly invade into host
tissues to cause infection.
Many different staphylococcal species are known to inhabit the human skin with
overlapping niches ultimately resulting in interspecies competition between the various
staphylococci (101). Like many species, staphylococcal species work to block key
signalling events in nearby species to diminish their growth. Specifically, staphylococcal
bacteria will block quorum-sensing signals from other staphylococcal species in the
surrounding area (102). Indeed, the autoinducing peptide produced by the agr system in S.
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epidermidis is known to be a potent inhibitor of the agr system in S. aureus (102,103). This
competitive advantage has been suggested as a reason for the predominance of S.
epidermidis on human skin (104). In contrast to S. epidermidis, which modulates the
growth and virulence of S. aureus, S. lugdunensis is able to directly kill co-colonizing S.
aureus. Initially it was noticed that although both S. aureus and S. lugdunensis colonize the
nasal cavity, but carriage of S. lugdunensis was associated with lower rates of S. aureus
colonization, suggesting competitive inhibition (96). Along with this observation it was
discovered that nasal colonizing strains of S. lugdunensis produce a novel antibiotic
product called “lugdunin,” which was bactericidal towards S. aureus (96). While S. aureus
is sensitive to competitive inhibition by other staphylococcal species, it does encode
defensive mechanisms allowing it to overcome competition from other species. One
example of a resistance mechanism employed by S. aureus when faced with competition
is the expression of catalase in the presence of Streptococcus pneumoniae invasion (105).
S. pneumoniae produces H2O2 in its local environment to kill competing bacteria, however,
S. aureus produces catalase, which functions to break H2O2 into water and oxygen
(105,106). It has been shown that strains of S. aureus deficient for catalase are less able to
resist killing by S. pneumoniae in vitro, clearly demonstrating the role of catalase for
competition during colonization (105). Competition between bacterial species is common
and takes on many different forms, but ultimately the best competitors will be able to
overwhelm other species in order to promote their own successful colonization.
1.5.2 Cooperative interactions
Many bacterial exoproducts could be considered cooperative as they benefit the
producing species, but also frequently confer some benefit to other microbes in the vicinity.
Exotoxins and siderophores are two examples of products that when secreted have the
potential to benefit multiple species (107,108). Exotoxins produced during infection can
bring about tissue damage as well as lysing host cells including leukocytes and erythrocytes
liberating nutrients, which are normally inaccessible. This then offers opportunistic
pathogens, that may not secrete their own exotoxins, a chance to gather these nutrients and
invade the damaged host tissues. For example, S. aureus a-toxin is known to target
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macrophages promoting the growth and dissemination of multiple species of Gramnegative bacteria during co-infection (97). Moreover, the need to gather nutrients such as
iron, which is normally sequestered by the host, is essential for nearly every bacterial
pathogen (109,110). To effectively acquire iron, several pathogenic species produce
siderophores that are able to bind and liberate the ferric iron from host proteins that
normally sequester any available iron (111). The siderophores complexed with iron can be
taken up by the bacteria and the iron can be used as it is required for growth and virulence
of multiple pathogens such as S. aureus, Pseudomonas aeruginosa, and Francisella
tularensis (112–114). While siderophores may not be an intentionally cooperative
interaction, they benefit the producing species, and are also able to benefit nearby bacteria
that express the corresponding receptors required for uptake. Many microbes encode
receptors for the uptake and use of siderophores that are produced by other species known
as “xenosiderophores” (95,108). P. aeruginosa is noteworthy for it not only produces two
of its own siderophores, pyoverdine and pyochelin, but also encodes receptors for several
other xenosiderophores (115) This serves to highlight the contribution of interspecies
interactions to the growth and dissemination of multiple species through tissue damage and
nutrient acquisition.
Staphylococcal species are particularly intriguing as they frequently compete, as
described previously, but are also able to cooperate with each other under certain
conditions. As discussed earlier S. lugdunensis and S. aureus cooperate through the
production of hemolytic exotoxins. S. lugdunensis secretes the SLUSH peptides, which are
minorly hemolytic on their own, but in the presence of S. aureus b-toxin are able to cause
potent red blood cell lysis (88). Furthermore, these two species cooperate through the
utilization of xenosiderophores. S. aureus produces and secretes two polycarboxylate
siderophores staphyloferrin A and B (SA and SB) to bind ferric iron (116,117). The
siderophores then bind to their cognate receptors on the bacterial surface, HtsABC is the
receptor for SA and SirABC is the receptor for SB, which are powered by the ATPase
FhuC to import iron-siderophore complex (118,119). S. lugdunensis does not produce its
own siderophores but does encode the HtsABC and SirABC receptors along with FhuC
allowing for import and utilization of SA and SB produced by S. aureus (95). Moreover,
coculture experiments have shown that the use of S. aureus’ siderophores enhance the
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growth of S. lugdunensis without compromising the growth of S. aureus confirming S.
lugdunensis is not parasitizing S. aureus, rather they are truly cooperating (95). The
synergistic effect of toxins from S. aureus and S. lugdunensis in addition to the ability of
S. lugdunensis to utilize SA and SB from S. aureus shows that these species are clearly
able to cooperate in vitro. Taken with the fact that S. lugdunensis is frequently found as
part of mixed culture infections, suggests that S. lugdunensis is capable of cooperating with
a number of different species including S. aureus under favourable conditions.
1.6 Project rationale and hypothesis
S. lugdunensis has emerged as an important pathogen with the capacity to cause a
variety of invasive infections that are clinically indistinguishable from those caused by S.
aureus. Until recently, S. lugdunensis has been underappreciated as a pathogen due to a
combination of factors including its misdiagnosis as S. aureus, its frequent occurrence in
mixed infections, and a lack of effective identification in clinical samples. S. lugdunensis
is recognized for its enhanced virulence compared to other CoNS and the emergence of
antibiotic resistant strains is making these invasive infections increasingly difficult to treat.
Despite the significance of S. lugdunensis, remarkably little is known about the
pathogenesis of this species and its interactions with macrophages have not yet been
investigated. The observation that S. lugdunensis is able to cause infections similar to S.
aureus and is regularly found in mixed infections, led me to hypothesize that S.
lugdunensis, like S. aureus, must be able to overcome immune restriction and resist killing
by host macrophages allowing for persistence within these cells, which then sensitizes the
host cells to subsequent infection by other pathogenic species such as S. aureus
1.7 Research objectives
To investigate my hypothesis, I pursued the three following research objectives:
1. Determine the subcellular location of S. lugdunensis within macrophages, and the
specific factors that allow S. lugdunensis to survive within these cells.
2. Determine the immune mechanisms restricting the growth of S. lugdunensis and the
outcome upon the initiation of intracellular replication.
3. Characterize the interactions of S. lugdunensis and S. aureus with macrophages in the
context of a co-infection.
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CHAPTER 2- MATERIALS AND METHODS
2.1 Reagents
Roswell Park Memorial Institute 1640 medium (RPMI) and fetal bovine serum
(FBS) were from Wisent Inc. (St. Bruno, QC, Canada). Paraformaldehyde 16% solution
and #1 thickness round cover glass slips (18mm diameter) were from Electron Microscopy
Sciences (Hatfield, PA, USA). The Cell Proliferation Dye eFluor® 670 was from
eBiosciences. 3.14μm silica beads were from Bangs Laboratories (Fishers, IN, USA).
Lyophilized human IgG was from Sigma Aldrich (St. Louis, MS, USA). Fluorescent
tetramethylrhodamine conjugated wheat germ agglutinin (TMR-WGA) and FITC-Avidin
488 were from Molecular probes, ThermoFisher Scientific. The rat anti-mouse LAMP-1
antibody (clone 1D4B) and the mouse anti-human LAMP-1 antibody (clone H4A3) were
obtained from the Developmental Studies Hybridoma Bank at the University of Iowa. Goat
anti-rat Alexa Fluor® 488 IgG, goat-anti rat and goat anti-human Cy3 conjugated IgG were
all purchased from Jackson Immunoresearch. For cell-culture recombinant human M-CSF,
IFN-γ, GM-CSF were purchased from Peprotech and LPS was from Sigma-Aldrich.
Concanamycin A (ConA), Pepstatin A and Antipain were purchased from Santa Cruz
Biotechnology. Diphenyleneiodonium (DPI) was purchased from Tocris Bioscience.
2.2 Bacterial Strains and Culture Conditions
S. aureus strain USA300 (plasmid cured) (120), Micrococcus luteus (42), S.
lugdunensis HKU09-01 (121), S. lugdunensis N920143 (81), and S. lugdunensis DoatA
mutant derived from HKU09-01 (this study) were used in this study (Table 1). Bacteria
were routinely cultured at 37°C in tryptic soy broth (TSB) (Difco) with shaking or on TSB
agar (1.5% w/v). When needed S. lugdunensis carrying a constitutive GFP/mCherry
expression vector pRSA-GFP/pAH9 (122) was cultured in the presence of erythromycin
(3 μg/mL) and lincomycin (20 μg/mL). When necessary the staphylococcal-selective
medium mannitol salt agar (MSA) was also used and bacteria were cultured on MSA at
37°C.
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Table 1. Bacterial strains and plasmids used in this study
Strain or Plasmid
Description
Strains
Micrococcus luteus
H3129

Source/Reference

Human skin commensal species

Laboratory stock

Staphylococcus aureus
USA300

USA300 LAC; MRSA cured of antibiotic
resistance plasmids

Laboratory stock

Staphylococcus lugdunensis
HKU09-01

Sequenced WT strain isolated from human skin
infection, Hemolytic on blood agar

Tse 2010 (121)

DoatA

markerless deletion of o-acetyltransferase in
HKU09-01 background

This study

N920143

Sequence WT strain isolated from a
breast abscess Non-hemolytic on blood agar

Heilbronner
2011(81)

Plasmids
pRSA-GFP

S. lugdunensis GFP constitutive expression
vector pRSA promoter, erythromycin resistance

Sayedyahossein
2014 (122)

pAH9

S. lugdunensis mCherry constitutive expression
vector, SarA promoter, erythromycin resistance

Boles 2008 (123)

pCG44

S. aureus GFP constitutive expression vector
SarA promoter, chloramphenicol resistance

Gries 2016 (124)

pLactC2-RFP

Mammalian expression vector encoding.
lactadherin-C2 domain fused to RFP

pKOR1-DoatA

Allelic replacement plasmid for deletion of oatA

S. Grinstiein
This study

2.3 Mammalian Cell Cultures
RAW 264.7 macrophages were from the American Type Culture Collection. RAW
264.7 macrophages were routinely cultured in RPMI 1640 (Wisent) buffered with sodium
bicarbonate and 25mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
supplemented with 5% (v/v) non-inactivated FBS (Wisent). Macrophages were passaged
by cell scraping and grown at 37°C in the presence of 5% CO . RAW macrophages were
2

passaged for no longer than 6 weeks prior at which time new cells were revived from liquid
nitrogen.
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Primary human macrophages were derived from peripheral blood monocytes
isolated from healthy volunteer blood samples. Monocytes were isolated as previously
described (42). In brief, monocytes were enriched for by virtue of their rapid adhesion to
glass coverslips. Differentiation of adhered monocytes was accomplished by culturing cells
as described above in RPMI supplemented with 10% (v/v) non-inactivated FBS and
antibiotics. For the differentiation of M0 macrophages adhered monocytes were cultured
in the presence of recombinant human M-CSF (10ng/mL) for 5 days followed by RPMI
containing 10% (v/v/) FBS and M-CSF without antibiotics for an additional 2 days.
Macrophages were used from days 7 to 10. To generate primary M1 polarized primary
human macrophages adhered monocytes were cultured as above however recombinant
human GM-CSF (20ng/mL) was used. At day 5 post-isolation the medium was replaced
with RPMI containing 10% (v/v) FBS without antibiotics but containing GM-CSF (20
ng/mL), recombinant human IFNγ (10 ng/mL) and LPS (250 ng/mL). Cells were used from
days 7 to 10.
2.4 Infection Assays and Enumeration of Gentamicin Protected Bacteria
All macrophages adhered to glass coverslips were infected with bacteria at a
multiplicity of infection (MOI) of ten unless otherwise stated. Bacteria were grown
overnight in TSB then pelleted and re-suspended in serum free RPMI and diluted to the
appropriate cell density. Bacteria were then added to macrophages that had been cultured
overnight in individual wells of 12 well tissue culture plate. To synchronize phagocytosis
tissue culture plates were centrifuged at 277 x g for 2 minutes and then incubated at 37°C
with 5% CO for 30 minutes. Next, cells were washed with PBS and the medium was
2

replaced with serum free RPMI containing gentamicin at 100 μg/mL for 60 minutes. For
some infection experiments either 0.02% or 0.002% Triton X-100 was added to the
macrophages after treatment with gentamicin to release the bacteria from the macrophages.
To enumerate gentamicin-protected cells at 1.5 hours post-infection the
macrophages were washed with PBS after gentamicin treatment and then lysed with sterile
water and 0.01% (v/v) Triton X-100 in PBS. For infections longer than 1.5 hours infected
cells were washed with sterile PBS and then incubated in RPMI containing 5% (v/v) FBS
without gentamicin. At 24 hours post-infection or longer as necessary the culture medium
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was collected and centrifuged to collect any bacteria having escaped from macrophages.
Adherent macrophages were lysed as described above and the cell pellet from the culture
medium was re-suspended in the Triton solution containing lysed macrophages and
gentamicin protected bacteria. The samples were serially diluted and plated to determine
the number of colony forming units.
In some instances, mock infections were performed as controls. The input bacterial
samples were prepared identically to those above but were added to individual wells of a
tissue culture plate without macrophages. The samples were grown in RPMI with 5% (v/v)
FBS at 37°C with 5% CO . These cells were not treated with gentamicin but were collected
2

at 1.5 and 24 hours post inoculation and were diluted and plated as above.
2.5 Biotinylation of bacteria.
Bacteria were surface biotinylated as previously described (125). In brief, bacteria
from an overnight culture were pelleted and washed in PBS pH 8.0. Next, the bacterial
pellet was re-suspended in 1 ml of PBS pH 8.0 containing 0.1 mg EZ-Link-NHS-LC Biotin
(Thermo Scientific) and incubated at room temperature for 10 min. Bacteria were then
pelleted and incubated for 2 min with 1 mL of TSB to quench any unreacted biotin. After
washing with PBS bacteria were re-suspended in serum free RPMI and used for infections
as described above. Biotinylated bacteria remaining outside macrophage were detected by
adding eBioscience™ streptavidin-FITC (Thermo Scientific).
2.6 Construction of a S. lugdunensis oatA mutant
Allelic replacement was performed using the pKOR1 plasmid as previously
described (126). In brief, the oatA-Attb1/oatA5’R, and the oatA3’F/oatA-Attb2 primer
pairs (Table 2) were used to PCR amplify 900-1100 base pair regions upstream and
downstream of the oatA gene. The fragments were cloned into the pKOR1 plasmid to
generate the pKOR1ΔoatA plasmid. This plasmid was obtained in E. coli DH5a and
passaged through E. coli SL01 to allow for proper DNA methylation so it could be
transformed into S. lugdunensis HKU09-01. Chromosomal recombination then resulted in
the deletion of the oatA gene from S. lugdunensis. Chromosomal deletions were confirmed
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by PCR amplification using the forward and reverse primers oatA-Check-F/R that anneal
to the chromosome flanking the entire the regions of homology.

Table 2. Oligonucleotides used for allelic replacement
Name
Sequence*
oatA-Attb1

5’GGGGACAAGTTTGTACAAAAAAGCAGGCTCAACAAATTTT
TGGAGG 3’

oatA5’R

5’GGACCTCCGCGGCTTAACTTGTAGTTCCG 3’

oatA3’F

5’ GGACCTCCGCGGCCATTGAACAAACAGAAAAAG 3’

oatA-Attb2

5’GGGGACCACTTTGTACAAGAAAGCTGGGTCCAGGATTTAC
AACACATG 3’

oatA-Check-F

5’ CAAATTTTATGTTATAGTTTCTAG 3’

oatA-Check-R

5’ GTTCTAAATTTAATGGAACGGGG 3’
Used for deletion of oatA from S. lugdunensis HKU09-01

* Restriction sites are underlined

2.7 Lysozyme MIC
Wild-type and oatA deficient S. lugdunensis bacteria were streaked onto TSA plates
and grown overnight at 37°C. Isolated colonies were inoculated into individual glass test
tubes containing 5mL TSB, in triplicate for each strain, and grown overnight with shaking.
The next day the bacteria were pelleted and washed with sterile 1xPBS and diluted to an
OD600nm of 0.5. Next a 1 in 100 dilution of these bacterial suspensions (final OD600nm
of 0.005) was used to inoculate RPMI supplemented with 0.5% (w/v) casamino acids in
the presence of lysozyme. Two-fold dilutions of lysozyme were used starting with 3600
µg/mL of lysozyme. Growth analysis was performed in 1 mL culture volumes in 13 mL
polypropylene round bottom sterile tubes and the OD600nm was determined at 20 h postinoculation allowing for MIC determination.
2.8 Polymyxin B MIC
Wild-type S. lugdunensis were used to infect M-CSF derived macrophages for a
typical gentamicin protection assay. At 1.5 hours post infection the macrophages were
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lysed, and the bacteria were collected. Meanwhile, WT S. lugdunensis that had not been
exposed to macrophages were diluted to an equal culture density as those collected from
the macrophages. 20µl of each culture was used to inoculate series of tubes with 2-fold
dilutions of Polymyxin B in RPMI with 5%FBS. The tubes were incubated at 37°C for 24
hours before the culture density was measured by its OD600.
2.9 Immunofluorescence Staining of LAMP-1
Macrophages were infected as above and at the desired time post-infection
macrophages were fixed with 4% (v/v) paraformaldehyde (PFA) for 20 minutes at room
temperature. The cells were then permeabilized with ice-cold methanol for 2 minutes and
then blocked with 1 mL 5% (w/v) skim milk in sterile 1x PBS for at least 1 hour.
Macrophages were then incubated for 1 hour at room temperature with either mouse antihuman LAMP-1 antibody (clone H4A3) or with rat anti-mouse LAMP-1 antibody (clone
1D4B) diluted 1:100 in blocking solution as appropriate. Cells were then rinsed and
subsequently incubated for 1 hour with 0.75 µg/mL of the appropriate fluorophore
conjugated secondary antibody diluted in blocking solution and then rinsed. LAMP-1
immunostained cells were analyzed by confocal or wide-field fluorescence microscopy.
2.10 Dextran Loading of Macrophages
Macrophages adhered to coverslips were incubated overnight with 10 kDa dextran
conjugated with FITC or TRITC at 100 μg/mL (Molecular Probes®, Thermo Fisher
Scientific) in complete tissue culture medium. Prior to infection dextran loaded
macrophages were washed with PBS and the medium was replaced with serum free RPMI
without dextran for at least 1 hour to allow for labelling of lysosomal compartments. After
this, infections were carried out as described above and at 1.5 hours post-infection the cells
were imaged live on a Leica TCS SP5 laser scanning confocal microscope.
2.11 eFluor Proliferation Assays
S. lugdunensis containing the pRSA-GFP plasmid were labeled with 5μg/mL
eBioscience™Cell Proliferation Dye eFluor™ 670 in 0.9% (w/v) saline for 5 minutes. The
bacteria were then washed with LB to quench the unreacted eFluor dye and were then re-
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suspended in serum free RPMI to carry out infections as described above. At 1.5 and 24
hours post infection the samples were fixed and imaged by wide field fluorescence
microscopy. In some instances, macrophages were either pre-treated or treated after
gentamicin exposure (i.e. 1.5 hours post-infection) with ConA (0.5 µM), DPI (10 µM),
Pepstatin A (100 µM) and Antipain (10 µg/mL) alone or in combination. Once added,
pharmacological agents were maintained throughout the entire experiment. In some
instances, propidium iodide was added to cells (1 µg/mL), which were then were imaged
live by fluorescence microscopy.
2.12 IgG opsonization and phagocytosis of beads
Silica beads (3.14 µm, Bangs Laboratories) were incubated for 1 hour with 0.8
mg/mL human IgG prior to washing. Next beads were added to macrophages and
centrifuged at 277 x g to synchronize binding of IgG coated beads to macrophages. After
a 30-minute incubation at 37°C an ant-human IgG conjugated to AlexaFluor-647 (0.75
µg/mL) was added to mark extracellular beads prior to fixation with 4% (v/v)
paraformaldehyde. Macrophages were then imaged by fluorescence microscopy and the
phagocytic index was determined by counting the number of internalized beads (i.e.
AlexaFluor-647 negative) divided by the total number of macrophages counted.
Macrophages without beads adhered to the cell surface were not included in the analysis.
2.13 Cytotoxicity Assay
Raw macrophages were seeded on to glass coverslips and incubated overnight
growing to a cell density of approximately 80% coverage. At the same time overnight
cultures of S. aureus USA300, S. lugdunensis HKU09-01, and S. lugdunensis N920143
were grown in TSB. These cultures were centrifuged and then passed through 2 separate
0.2µm filters to remove the bacteria. 100µL of each culture supernatant as well as a TSB
control was each added to 900µL of RPMI with 5% FBS and added to separate wells of
macrophages. The cells were incubated at 37°C with the supernatants for 2 hours at which
time propidium iodide was added and the cells were imaged live by fluorescent microscopy
to quantify cell death in each sample.
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2.14 Lact-C2 Transfection of RAW macrophages
The Lact-C2 expression vector (1µg/mL) was added to the Fugene transfection
reagent at a ratio of 1µL:3µL in 100uL of serum free DMEM per well of macrophages to
be transfected. This mixture was vortexed and incubated at room temperature for 10
minutes. 100µL was added dropwise to each well and the plate was gently shaken to mix.
The cells were then incubated at 37°C overnight and then used for infections as normal.
2.15 Fluorescence Microscopy
Laser scanning confocal microscopy was performed using a Leica TC5 SP5
microscope composed of a DMI6000 CS inverted microscope. The microscope contains an
argon/2 (458, 476, 488, and 514nm) HeNe1 (543nm) HeNe2 (633nm) lasers and a PL-Apo
63x oil immersion objective lens. The microscope also contains a triple dichroic
(488/543/633) a double dichroic (488/543) and a tunable Acousto-Optical Beam Splitter
for all laser lines. All confocal Imaging was done at the Robarts Research Institute Imaging
Facility (The University of Western Ontario).
Wide field fluorescence and differential interference contrast (DIC) microscopy
was performed on a Leica DMI6000 B inverted microscope. The microscope is equipped
with 40x (NA 1.3), 63x (NA 1.4), and 100x (NA 1.4) oil immersion PL-Apo objectives, a
Leica 100W Hg high-pressure light source and a Photometrics Evolve 512 Delta EM-CCD
camera. Deconvolution of wide-field images acquired as z-stacks was done using the Leica
LAS X software.
For acquisition of S. lugdunensis in eFluor-670 proliferation assays acquisition
parameters for far-red fluorescence within each experiment were established on 1.5 h
samples where all bacteria were eFluor-positive. EM gain (~50), excitation intensity
(100%), and exposure time (~60 ms) was set to obtain maximal fluorescence without
achieving saturation of the far-red eFluor-670 signal at the 1.5 time point where the signal
would be greatest. The acquisition parameters established for each 1.5 h sample were
applied to the 24 h samples to identify bacteria that had become eFluor-negative due to
dilution of the dye as a consequence of bacterial replication. Enumeration of replication
was completed by comparing the number of macrophages containing replicating bacteria,
defined here as a foci of >1 cocci with total loss of eFluor, to the total number of
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macrophages containing bacteria. Images were acquired using either the 63x or 100x
objectives and images were processed using Image J software (127) for contrast
enhancement always with a gamma setting of 1. Images were cropped as necessary using
Image J after contrast enhancement and finally scale bars were applied to each image series.
2.16 Transmission Electron Microscopy
Macrophages infected with S. lugdunensis were fixed with 2% (v/v) glutaraldehyde
in 0.2M Sorenson’s phosphate buffer (pH 7.2) for 5 minutes after which the cells were
scraped off the coverslip, pelleted by centrifugation and re-suspended in fixative for an
additional 2 hours. Fixed macrophages were subsequently embedded in agarose and postfixed with 0.5% (w/v) osmium tetroxide for 2 hours at room temperature. Next, cells were
stained en bloc for 1 hour with 1% (w/v) uranyl acetate in dH2O. Samples were then
progressively dehydrated with increasing concentrations of acetone and then embedded in
Epon-Araldite resin. Eighty-nanometer thick sections were cut and placed on copper grids
to allow viewing with a Philips CM10 transmission electron microscope. Images were
taken using a Hamamatsu Orca 2 MPx HRL camera.
2.17 Murine model of systemic infection.
All protocols for murine infection were reviewed and approved by the University
of Western Ontario’s Animal Use Subcommittee, a subcommittee of the University
Council on Animal Care. Six-week-old, female, BALB/c mice were obtained from Charles
River Laboratories and housed in microisolator cages. S. lugdunensis strains were grown
to exponential phase (OD600 2 - 4) in TSB, washed twice with PBS, and resuspended in
PBS to an OD600 of 0.50. In instances where S. lugdunensis was heat-inactivated the
bacterial suspension at an OD600 of 0.5 were heated at 80°C for 30 min and plated on TSA
to confirm bacterial killing. For injections, 100 µL of the bacterial suspension, equivalent
to ~2-3 x 107 CFU, was injected into each mouse via tail-vein. After 8 hrs of infection mice
were anesthetized and euthanized via cervical dislocation. Livers were aseptically
harvested into ice-cold PBS with 0.1% (v/v) Triton X-100, homogenized, serially diluted
and plated onto TSA to enumerate bacterial burden. Bacterial burden from liver is
presented as log10 CFU per liver.
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In instances of co-infection, S. lugdunensis was cultured and injected as described
above. To prepare S. aureus USA300, the bacteria were cultured in TSB until midexponential phase (OD ~2.0-2.5) and then washed twice with sterile 1x PBS. The bacterial
suspension was diluted to an OD equivalent of 0.3. 100 µL of bacterial suspension,
equivalent to ~3-4 x 106 CFU, was injected into each mouse via tail-vein. Injections with
S. aureus USA300 were performed 16 h post-infection with S. lugdunensis. At 8 h post-S.
aureus infection and a total of 24 h for S. lugdunensis. Mice were euthanized as described
above and livers were harvested, homogenized and serially diluted. Diluted homogenates
were plated TSA and MSA and the bacterial burdens, presented as Log10 CFU/mL, were
determined.

2.18 Intravital spinning disk confocal microscopy
For whole animal imaging studies experiments were performed with 6–10-wk old
adult male mice, following protocols approved by the University of Calgary Animal Care
Committee and in compliance with the Canadian Council for Animal Care Guidelines. All
animals were maintained in a specific pathogen–free environment at the University of
Calgary Animal Resource Centre and mice were housed under standardized conditions for
temperature (21–22°C) and illumination (12 h light/12 h darkness) with constant access to
tap water and food.
For injections, a tail vein catheter was inserted into mice anesthetized with 200
mg/kg ketamine (Bayer Animal Health) and 10 mg kg−1 xylazine (Bimeda-MTC). Surgical
preparation of the liver for intravital imaging was performed as described previously (128).
Mouse body temperature was maintained at 37°C with a heated stage and image acquisition
was performed using Olympus IX81 inverted microscope, equipped with an Olympus
focus drive and a motorized stage (Applied Scientific Instrumentation). Objectives position
was controlled with a motorized objective turret equipped with 4×/0.16 UPLANSAPO,
10×/0.40 UPLANSAPO, and 20×/0.70 UPLANSAPO objective lenses and coupled to a
confocal light path (WaveFx; Quorum Technologies) based on a modified Yokogawa
CSU-10 head (Yokogawa Electric Corporation). Kupffer cells were visualized in vivo by
i.v. injection of 2.5 µg fluorescently conjugated anti–F4-80 mAb (clone BM8). S.
lugdunensis bacteria were visualized through constitutive expression of GFP and 1.0 x 107
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bacteria were injected per mouse. Laser excitation wavelengths 491, 561, 642, and 730 nm
(Cobolt) were used in rapid succession, together with the appropriate band-pass filters
(Semrock). A back-thinned EMCCD 512 × 512 pixel camera was used for fluorescence
detection (Hamamatsu). Volocity software (Perkin Elmer) was used to drive the confocal
microscope and for image acquisition and analysis. The find objects function in Volocity
software was used to identify individual bacteria that were captured by KCs (F4/80+ cells
in liver) and to determine the fluorescence intensity per particle.
2.19 Statistical Analysis
Data are presented as the mean ± SD. All statistical analyses and graph production
were done through GraphPad Prism (GraphPad Software, La Jolla, CA). Data were
analyzed using unpaired t-tests or a one-way analysis of variance with either Dunnett’s or
Bonferroni’s multiple comparison test as indicated. *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001.
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CHAPTER 3 – RESULTS
3.1 S. lugdunensis resides within macrophages for extended periods of time without
replicating.
To explore the interaction of S. lugdunensis with macrophages, gentamicin
protection assays were performed using the murine macrophage cell line RAW 264.7
(hereafter called RAW) and primary human M-CSF-derived macrophages. Macrophages
were allowed to phagocytose S. lugdunensis HKU09-01 and, at 1.5 hours post-infection
(after gentamicin treatment), viable S. lugdunensis were recovered from infected RAW and
primary human cells (Figure 1A-B). At 24 hours post-infection, viable S. lugdunensis was
recovered from infected macrophages, however, it was evident that the burden of S.
lugdunensis was unchanged over the 24-hour period (Figure 1A-B). To verify that this
observation was unique to S. lugdunensis, parallel infections were performed using S.
aureus USA300 and Micrococcus luteus, representative bacteria previously established to
overcome macrophage restriction or to be killed, respectively (42). Consistent with
previous observations M. luteus, although recovered at 1.5 hours post-infection, was
eradicated by 24 hours (Figure 1A-B). In contrast to S. lugdunensis and M. luteus, S. aureus
USA300 grew over the same 24-hour period indicating the macrophages failed to restrict
S. aureus (Figure 1A-B) It is worth noting that S. lugdunensis was able to grow in the tissue
culture media when no macrophages are present (Figure 1C), indicating the macrophages
specifically are responsible for restricting S. lugdunensis. To determine whether S.
lugdunensis could persist intracellularly for an extended period of time, infected primary
human macrophages were monitored over 72 hours (Fig. 1D). This analysis demonstrated
that at 48 and 72 hours post-infection, viable S. lugdunensis could be recovered from
macrophages, although at 72 hours a modest, yet statistically significant decrease in
bacterial viability was observed (Fig. 1D).
eFluor proliferation assays were used to investigate whether S. lugdunensis was in
equilibrium between growth and death or was truly not replicating within host cells. To
this end GFP-expressing S. lugdunensis were labelled with the far-red proliferation dye
eFluor670 such that at the outset of the experiment all phagocytosed bacteria were GFPand eFluor670-positive and those that replicate would dilute and lose the eFluor dye.
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Primary human M-CSF-derived macrophages, at 1.5 hours post-infection and, remarkably,
at 24 hours post-infection, contained GFP and eFluor-positive S. lugdunensis exclusively,
indicating that the bacteria had not replicated at all over this period of time (Figure 1E).
Taken together these data indicate that S. lugdunensis demonstrates a unique intracellular
fate as compared to S. aureus and M. luteus wherein the bacteria remain viable within
macrophages for extended periods of time but do not replicate in this intracellular niche.
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Figure 1. Macrophages fail to kill intracellular S. lugdunensis but restrict bacterial
growth. In (A-C) Macrophages/empty wells were infected at an MOI of 10 and the number
of gentamicin-protected bacteria at 1.5 and 24 hours post-infection was determined. S.
lugdunensis HKU09-01 was found to survive while, S. aureus USA300 grows and M.
luteus is killed within RAW 264.7 (A), or M-CSF-derived primary human macrophages
(B). Part (C) demonstrates that S. lugdunensis can grow in the tissue culture media in the
absence of macrophages. In (D) S. lugdunensis was shown to survive for as long as 72
hours post-infection before a decrease in CFUs was observed. The data presented represent
the mean CFU/mL ± S.D. of three independent experiments. Statistical significance was
determined by Dunnett’s multiple comparison test where * P <0.05 and ** P <0.01. In (E)
representative confocal micrographs depict primary human M-CSF-derived macrophages
(red) at 1.5 (top panels) and 24 hours (bottom panels) post-infection with GFP-expressing
S. lugdunensis bacteria (green), that were co-labelled with eFluor670-prolfieration dye
(blue) at an MOI of 10. White boxes indicate regions displayed in insets, and white arrows
point to cocci that remain eFluor670-positive, indicating the bacteria have not replicated
over a 24 hours period. Images are representative of at least three independent experiments,
scale bars equal 10 µm.

3.2 Phagocytosed S. lugdunensis are trafficked to mature phagolysosomes in
macrophages.
I next sought to identify the subcellular niche occupied by phagocytosed S.
lugdunensis. Particulates ingested by macrophages are brought into phagosomes and are
rapidly matured into lysosome-associated membrane protein 1 (LAMP-1)-positive
phagolysosomes. To determine whether phagocytosed S. lugdunensis are contained within
phagolysosomes demarcated by LAMP-1, RAW and primary human M-CSF-derived
macrophages were infected and immunostained using anti-LAMP-1 antibody to be
visualized by microscopy. This analysis revealed that at 1.5 hours post-infection the
majority (~80%) of intracellular S. lugdunensis colocalize with the LAMP-1 protein as
indicated by the accumulation of anti-LAMP-1 fluorescence around intracellular cocci in
RAW (Figure 3A) and M-CSF derived macrophages (Figure 2A and C). To confirm that
ingested S. lugdunensis reside in mature phagolysosomes I also performed dextran pulse-

32
chase experiments to fluorescently label lysosomes, which fuse with phagosomes during
infection. This analysis revealed that in both RAW (Figure 3B) and primary human
macrophages (Figure 2B and. D), roughly 80% of intracellular S. lugdunensis colocalize
with lysosomal dextran, identical to LAMP-1. This together shows that intracellular S.
lugdunensis bacteria are quickly trafficked to and reside within mature phagolysosomes of
macrophages.
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Figure 2. S. lugdunensis is trafficked into LAMP-1 and dextran positive
phagolysosomes. The maturation state of the S. lugdunensis-containing phagosome in
primary human M-CSF-derived macrophages was analyzed. In (A) Infected cells were
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immunostained demonstrating the accumulation of the LAMP-1 protein (red) around
eFluor (blue) labeled S. lugdunensis and remaining extracellular were differentiated with
FITC-avidin (green). In (B) primary human macrophages were loaded with TRITC-dextran
(in red) that was chased into lysosomes prior to infection with GFP-expressing S.
lugdunensis (MOI = 10). The white boxes indicate the region of the cells displayed in the
inset panels and the white arrows point to intracellular S. lugdunensis that are clearly
demarcated by LAMP-1 (A) or TRITC-dextran (B). In (A) and (B) representative confocal
micrographs taken from three independent experiments are shown. Scale bars in (A) and
(B) equal 10 µm. In (C) and (D) the quantitation of intracellular bacteria that from (A) and
(B) as well as experiments in RAW cells shows that over 80% of intracellular S.
lugdunensis reside in LAMP-1/dextran positive phagolysosomes at 1.5 hours post
infection. The data presented are the mean ± S.D and images shown are representative of
those derived from three independent experiments using primary macrophages from three
independent donors. n.s. indicates the means are not significantly different as determined
by a student’s unpaired t test.
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Figure 3. S. lugdunensis colocalizes with LAMP-1 and lysosomal dextran in RAW
macrophages. Similar to before, the intracellular location of S. lugdunensis within RAW
macrophages was determined through colocalization with endogenous LAMP-1 protein
(A) and lysosomal dextran (A). Macrophages were infected with an MOI of 10 and were
fixed with 4% paraformaldehyde (A) or imaged live (B) at 1.5 hours post infection. Arrows
indicate staphylococci that are colocalizing with LAMP-1 (red) in (A) and FITC-dextran
(green) in (B). The white boxes in the lower panel indicate the region of the cell depicted
in the inset panels. Images shown are confocal (A) and widefield (B) micrographs, that are
representative of three independent experiments.

3.3 S. lugdunensis resides within Kupffer cells in murine livers.
Given that S. lugdunensis is able to survive long periods of time when residing
inside macrophages in vitro, I sought to determine whether or not S. lugdunensis is able to
inhabit this niche in vivo. To this end, a systemic murine model of infection was utilized,
which has previously been established that S. aureus are phagocytosed by, and reside
within, liver resident Kupffer cells (68). To begin I needed to establish that S. lugdunensis
could indeed infect the murine liver and reside within Kupffer cells. To this end live GFPexpressing S. lugdunensis were injected intravenously into anesthetized animals and
bacterial localization in the liver was monitored over time by intra-vital microscopy (Figure
4A and B). By 15 minutes post-injection, live GFP-expressing S. lugdunensis were
visualized in the liver where they colocalized with F4/80+ Kupffer cells (Figure 4A).
Importantly, GFP-positive S. lugdunensis bacteria were detectable in association with
F4/80+ Kupffer cells for at least 16 hours post-infection (Figure 4C). Notably, there was no
evidence that the bacteria were replicating indicated by the absence of any increase in GFP
fluorescence (Figure 4C). To verify that the bacteria were viable, infections were repeated
with heat-inactivated GFP-positive S. lugdunensis. Killed S. lugdunensis were rapidly
captured by F4/80+ Kupffer cells however, unlike live S. lugdunensis, killed S. lugdunensis
were degraded by 4 hours post-infection as indicated by the absence of detectable GFP
fluorescence (Fig 4B and C). Together these data revealed that S. lugdunensis is captured
by Kupffer cells in vivo and that these bacteria can remain viable within these cells long
after infection.
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Figure 4. S. lugdunensis are captured by Kupffer cells (KCs) in the murine liver where
the bacteria resist killing. In (A) and (B) intra vital spinning disk confocal images show
the capture of live and dead GFP-positive S. lugdunensis. Kupffer cells, marked by their
labeling with fluorescent F4/80 antibody (in red). Images depict KC/S. lugdunensis
interaction at 15 min (A) and 4 h post-injection (B). In (C) the presence of live and dead S.
lugdunensis inside KCs is shown over time. The data were derived from 3 mice for each
time point with 10 fields of view taken from each mouse and are presented as the mean
number of GFP-positive S. lugdunensis bacteria detected per field of view ± standard error
of the mean. Scale bars equal ~20 µm.
3.4 S. lugdunensis is sensitized to exogenous sources of stress after being phagocytosed
by macrophages.
The next goal was to identify if that the inability of S. lugdunensis to grow within
the macrophage could be due to the absence of an essential nutrient that is excluded from
the phagolysosome. To test this notion infected macrophages were permeabilized after
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phagocytosing S. lugdunensis as this would permit access to nutrients in the tissue culture
medium that would have been excluded from the phagosome. Infections of primary human
M-CSF-derived macrophages (Figure 5A) or media-only mock infections (Figure 4B) were
performed where at 1.5 hours post-infection, either vehicle control or 0.02% (v/v) triton X100 was added to the culture media and at 24 hours post-infection bacterial proliferation
was evaluated by plating for colony forming units. Viable S. lugdunensis were recovered
at 1.5 hours post-infection confirming viable S. lugdunensis were present at the time TritonX100 was added to the cultures (Fig. 5A and B). Interestingly, at 24 hours post-infection
viable S. lugdunensis were only recovered from vehicle control treated macrophages
(Figure 5A). Surprisingly, in the presence of 0.02% (v/v) triton X-100 the growth of S.
lugdunensis was not only inhibited but viable bacteria could no longer be detected (Fig.
5A). This result was surprising given that mock infection experiments demonstrated that
S. lugdunensis could in fact replicate in the tissue culture media containing either vehicle
control or 0.02% (v/v) triton X-100 (Fig. 5B), suggesting the macrophages sensitized the
bacteria to killing by the detergent. To determine whether phagocytosed S. lugdunensis are
generally more sensitized to exogenous sources of stress, viable S. lugdunensis were
recovered from infected M-CSF-derived macrophages at 1.5 hours post-infection and
plated these bacteria (labeled Post) on the permissive medium, tryptic soy agar (TSA,
Figure 5C right), as well as selective medium, mannitol salt agar (MSA, Figure 5C left). In
parallel, control S. lugdunensis never having been exposed to macrophages (labeled “Pre”)
were also plated on TSA and MSA and as expected control bacteria grew equally well on
both media (Fig. 5C). In contrast, phagocytosed S. lugdunensis grew on TSA but was
significantly impaired on MSA (Fig. 5C). Furthermore, phagocytosed S. lugdunensis were
also sensitized to the antimicrobial peptide polymyxin B (PmxB) as S. lugdunensis that had
been phagocytosed by M-CSF derived macrophages demonstrated increased sensitivity to
PmxB in liquid culture, relative to control bacteria (Figure 5D) Taken together these
observations indicate that phagocytosed S. lugdunensis, despite remaining viable, are
rapidly modified within macrophages in such a way that sensitizes the bacteria to
exogenous stress.
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Figure 5. S. lugdunensis demonstrates increased sensitivity to stress in vitro after
being phagocytosed by macrophages. In (A) M-CSF-derived macrophages were infected
with S. lugdunensis using an MOI of 10. At 1.5 hours post-infection the cells were treated
with either vehicle control or 0.02% (v/v) triton X-100 and the resulting colony forming
units for S. lugdunensis was determined at 24 hours post-infection for the control, sample
but the triton-treated samples recovered no viable bacteria. The same was done in (B) but
bacteria were inoculated into tissue culture media lacking macrophages, and all samples
grew normally. Shown are the mean ± S.D. CFU/mL derived from three independent
experiments (** P<0.01 **** P<0.0001). In part (C) S. lugdunensis recovered from
primary human M-CSF-derived macrophages 1.5 hours post-infection (labeled Post) was
unable to grown on staphylococcal selective mannitol salt agar (left) but grew normally on
tryptic soy agar (right). As a control S. lugdunensis never having been phagocytosed
(labeled Pre) is able to grow normally on both types of media. The images are
representative of three independent experiments. In (D) bacteria were recovered from M-
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CSF derived human macrophages after gentamicin treatment and used to inoculate RPMI
containing PmxB at the indicated concentrations. S. lugdunensis that have been
phagocytosed were more sensitive to PmxB than naive S. lugdunensis. These data are the
mean OD600nm reading ± S.D. from three independent experiments (** P<0.01).

3.5 The peptidoglycan acetyl-transferase oatA contributes to the survival of S.
lugdunensis within macrophages.
To determine whether the ability of S. lugdunensis to persist within macrophages
requires the active metabolic function of the bacteria to counter macrophage attack I
constructed a deletion mutant of S. lugdunensis that lacks the O-acetyl-transferase oatA.
OatA is responsible for acetylating peptidoglycan, which offers Staphylococcus bacteria
resistance to lysozyme attack (55). In vitro growth experiments demonstrated that S.
lugdunensis lacking oatA were ~8 fold more sensitive to lysozyme as compared to wildtype bacteria (Figure 6A). Indeed, oatA-deficient S. lugdunensis were incapable of growth
at lysozyme concentrations in excess of 200 µg/mL where as wild-type S. lugdunensis are
able to grow at lysozyme concentrations ≥ 3200 µg/mL (Fig 6A). Next the oatA mutant
was analyzed for its ability to survive within RAW macrophages (Figure 6B). To this end
gentamicin protection assays were performed and at 1.5 hours post-infection wild-type and
oatA-deficient S. lugdunensis were recovered from macrophages, however at 24 hours
post-infection it was evident that while WT S. lugdunensis persisted inside the macrophage,
there was a ~7 fold decrease in CFU/mL at the same time point for the oatA mutant (Fig
6B). While these data reveal that inside macrophages oatA-deficient S. lugdunensis were
less able to survive as compared to wild-type, but clearly the bacteria were not eradicated
entirely. To confirm that oatA is important for survival in vivo, mice were infected
systemically with wild-type S. lugdunensis and the oatA mutant and the bacterial burden in
livers was determined at 8 h post-infection (Figure 6C). In agreement with our intra vital
imaging data it was found that live wild-type S. lugdunensis bacteria were readily recovered
from livers at 8 h post-infection (Figure 6C). Moreover, I found that significantly fewer
oatA-deficient S. lugdunensis bacteria were recovered at the same time point (Figure 6C).
In summary, these data reveal that oatA in S. lugdunensis contributes to lysozyme
resistance and bacterial survival within macrophages in vitro and in vivo, however clearly
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there are other factors contributing to the ability of S. lugdunensis to evade immune attack
within the phagolysosome.
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Figure 6. Deletion of the oatA gene sensitizes S. lugdunensis to lysozyme and
intracellular killing in macrophages. In (A) the ability of an oatA to grow in the presence
of lysozyme in tissue culture media was greatly reduced compared to WT S. lugdunensis.
These data are the mean OD600 reading ± S.E.M of three biological replicates for each
strain and are representative of four independent experiments. In (B) Macrophages were
infected with an MOI of 10 and the CFU/mL for each strain was determined at 1.5 hours
and 24 hours post-infection, with the oatA mutant having significantly reduction in CFUs
by 24 hours post-infection compared to WT. These data are the mean ± S.E.M. of at least
four independent experiments and a total of ten biological replicates. (**** indicates
p<0.0001, unpaired t test). In (C) the bacterial burdens from murine livers taken from
BALB/c mice infected with wild-type S. lugdunensis or an oatA-deficient mutant
demonstrate that the mutant has reduced survival in vivo. Burdens are presented as the
Log10 CFU/mL. *** indicates p<0.0001 as determined by Student’s t-test.
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3.6 Perturbation of phagolysosome function enables S. lugdunensis to proliferate with
Raw macrophages.
Ostensibly, the rapid restriction of S. lugdunensis by macrophages can be attributed
to antimicrobial effectors that are active in the phagolysosome. To determine whether
phagolysosome function is indeed responsible for growth restriction of S. lugdunensis I
utilized pharmacologic inhibitors known to perturb various effectors that should be active
during phagocytosis and phagosome maturation. As such macrophages were treated with
either the vacuolar-ATPase inhibitor Concanamycin A (ConA), the protease inhibitors
Pepstatin A and Antipain, the NADPH oxidase inhibitor Diphenyleneiodonium (DPI), or a
combination thereof. Macrophages were left untreated or pre-treated with each inhibitor
alone or in combination and then infected with S. lugdunensis expressing GFP co-labeled
with eFluor670 with the inhibitors maintained throughout the infection. It was found that
inhibitor treatment did promote the proliferative capacity of S. lugdunensis within RAW
macrophages as GFP-positive eFluor670-negative S. lugdunensis could be visualized
inside macrophages at 24 hours post-infection (Figure 7A, right panels and B). This was in
stark contrast to untreated control macrophages where all intracellular bacteria, even at 24
hours post-infection, remained eFluor670-positive (Figure 7A left panels and B).
Quantitation of the fraction of macrophages containing replicating bacteria revealed that
treatment of macrophages with ConA or protease inhibitors alone permitted replication
within approximately 8 to 12% of macrophages and the simultaneous treatment of
macrophages with ConA and protease inhibitors did not have an additive effect (Fig 7B).
Interestingly, the combined treatment of macrophages with each inhibitor, including DPI,
increased the fraction of cells containing replicating S. lugdunensis to ~ 25-30% despite
the observation that DPI alone was without effect (Figure 7B).
To verify that the ability to elicit growth of intracellular S. lugdunensis was
somewhat unique to this pathogen I next performed infection assays with M. luteus in the
presence and absence of the same cocktail of inhibitors that allow S. lugdunensis to
proliferate. In these experiments, M. luteus could be recovered from untreated and inhibitor
treated cells at 1.5 hours post-infection, but by 24 hours no viable M. luteus could be
recovered (Figure 8). This shows that intracellular replication due to phagosomal

41
perturbation is at least somewhat specific to S. lugdunensis as the compartment clearly
maintains a significant level of antimicrobial activity.
3.7 Perturbation of Vps34 in primary human macrophages allows S. lugdunensis to
replicate intracellularly.
While the preceding experiments were performed using RAW macrophages I next
sought to confirm that even in primary human macrophages S. lugdunensis could replicate
intracellularly. Interestingly, pre-treatment of M-CSF-derived human macrophages with a
combination of DPI, ConA, Antipain and Pepstatin A failed to promote intracellular growth
of S. lugdunensis (Fig 7C). Conceivably, the antimicrobial effectors that are expressed or
the abundance of a given effector differs between RAW and human macrophages and this
could account for this deviation from our RAW cell data. As an alternate means to perturb
phagosome function I employed the PI3-kinase inhibitor PIK-III to disrupt Vps34 activity
and biosynthesis of PI(3)P. The phosphoinositide PI(3)P is an important signaling lipid that
influences NADPH oxidase function at the phagosome, and participates in phagosome
maturation and in the formation of autophagosomes (38). Next, I tested the ability of PIKIII treatment post-phagocytosis to promote S. lugdunensis growth within M-CSF-derived
human macrophages. As previously observed, macrophages treated with vehicle control
restricted S. lugdunensis proliferation entirely, however in the presence of PIK-III, GFPpositive yet eFluor-negative S. lugdunensis could be found within ~22% of the macrophage
population indicating S. lugdunensis grew intracellularly (Figure 7C). In parallel, antiLAMP-1 immunostaining was performed at 2 hours post-infection to establish whether S.
lugdunensis, in the presence of PIK-III, colocalized with LAMP-1-positive membranes.
Despite treatment with PIK-III intracellular S. lugdunensis bacteria were found within
LAMP-1 positive compartments at a nearly equal rate as in untreated cell as visualized by
confocal microscopy (Fig 7D). These data indicate that pre-treatment of macrophages with
PIK-III allowed S. lugdunensis to replicate within a significant fraction of primary human
M-CSF-derived macrophages, however not all aspects of phagosome maturation were
disrupted upon PIK-III treatment.
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Figure 7. Pharmacological treatment of S. lugdunensis infected macrophages with
protease inhibitors enables intracellular bacterial growth. RAW 264.7 macrophages
were pretreated with 500 nM concanamycin A (v-ATPase inhibitor) alone, Antipain and
Pepstatin A (protease inh.), 1 µM DPI (NADPH oxidase inhibitor) alone or a combination
of all inhibitors and infected with GFP-expressing, eFluor (blue) labeled S. lugdunensis. In
(A) the fluorescent micrographs show vehicle control treated macrophages (red) with
eFluor-positive S. lugdunensis (left panels) and inhibitor treated macrophages with eFluornegative S. lugdunensis (right panels). Representative images from three independent
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experiments are shown. The white boxes indicate which region of the cell is displayed in
the inset. In (B) quantitation of the number of macrophages containing replicating bacteria
in the presence of the various inhibitor treatments is shown for RAW macrophages. In (C)
M-CSF derived macrophages containing were pretreated with PIK-III (Vps34 inhibitor)
and infected with S. lugdunensis and the quantitation of macrophages containing
replicating bacteria is shown. Part (D) shows the fraction of S. lugdunensis that colocalize
with LAMP-1 in M-CSF derived macrophages at 1.5 hours post infection was not changed
from control levels when the macrophages were treated with PIK-III. The data are
presented as the mean ± S.D. calculated from three independent experiments. * P<0.05,
*** P<0.001.
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Figure 8. Perturbation of phagosome function does not rescue M. luteus. RAW
macrophages were infected with M. luteus at an MOI of 10 and gentamicin assays were
performed to enumerate the number of CFUs. Prior to infection macrophages had been pretreated with either PIK-III or a combination of DPI, Antipain, Pepstatin and Concanamycin
A. These data are the mean CFU/mL ± S.D. from three independent experiments where
macrophages were lysed at 1.5 and 24 hours post-infection. # Indicates values below the
limit of detection for these experiments.
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3.8 Proliferating S. lugdunensis escape phagosomal containment
The data presented thus far have shown that we can manipulate the macrophage
pharmacologically to permit intracellular replication of S. lugdunensis strain HKU09-01. I
next sought to determine whether replicating S. lugdunensis remain within the
phagolysosome. LAMP-1 immunofluorescence analyses, performed as before, showed that
at 24 hours post-infection, using either RAW or primary human macrophages, nonreplicating bacteria remain within LAMP-1-positive compartments (Figure 9A top panels
and B) while, remarkably and in contrast to what has previously found for S. aureus (42),
intracellularly replicating S. lugdunensis (i.e. that are eFluor-negative) were rarely
demarcated LAMP-1 fluorescence (Figure 9A, bottom panels, B and C). It is worth noting
that the results of the LAMP-1 immunostaining were repeated using S. lugdunensis
N920143 where eFluor negative bacteria were LAMP-1 negative, and eFluor positive
bacteria were LAMP-1 positive (Figure 10). This serves to demonstrate that the phenotype
is not an artefact of the initial strain tested.
Conceivably, replicating bacteria are no longer constrained by a vacuole, to analyze
this scenario, RAW macrophages, prior to infection, were transfected with a plasmid
encoding LactC2-RFP, a biosensor for phosphatidylserine (PS). Importantly, PS is found
throughout the cell in the cytoplasmic face of the plasma membrane as well as
compartments comprising the endo/lysosomal network, and numerous vacuolar structures,
where S. lugdunensis could be located (129). At 24 hours post-phagocytosis, analysis of
the distribution of LactC2-RFP showed that non-replicating S. lugdunensis and
phagocytosed IgG-coated beads remained LactC2-RFP positive (Figure 9D top and bottom
panels). In contrast replicating S. lugdunensis were not demarcated by the Lact-C2 lipid
biosensor and are thus not in any PS-positive vacuole (Fig 9D middle and bottom panels).
These latter observations confirm that the exclusion of LactC2-RFP from around
replicating S. lugdunensis is not due to a global disturbance in PS localization. To confirm
these observations, macrophages infected with S. lugdunensis were also visualized by
transmission electron microscopy at 24 h post-infection in the presence and absence of
inhibitor treatment. This analysis confirmed that non-replicating S. lugdunensis remain
confined to small vacuoles enclosed by continuous electron dense membrane (Figure 9E).
In contrast, replicating S. lugdunensis reside in large vacuolar structures containing
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Figure 9. Non-replicating S. lugdunensis remain constrained by LAMP-1-positive
membranes while replicating S. lugdunensis are LAMP-1 and PS negative. RAW
macrophages were treated with an inhibitor cocktail then infected with S. lugdunensis
expressing GFP that were labelled with proliferation dye and at 24 hours post-infection
cells were immunostained for LAMP-1. (A) shows that eFluor-positive S. lugdunensis
remain LAMP-1 positive (top panels), while eFluor-negative bacteria had become LAMP1 negative (bottom panels). In (B) quantitation of the fraction of LAMP-1 positive bacteria
that are replicating or not replicating is shown. These data presented are the mean ± S.D.
of at least three independent experiments (student’s unpaired t test, ** P<0.01). Shown in
(C) the absence of LAMP-1 around replicating S. lugdunensis in primary human M-CSFderived macrophages that were treated with PIK-III similar to what was observed in (A).
This image is representative of three independent experiment. Images are representative of
three

independent

phosphatidylserine

experiments.
lipid
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shown.

expressing
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macrophages were treated with an inhibitor cocktail then infected with S. lugdunensis in
the presence and absence of IgG opsonized beads. In the top panels non-replicating bacteria
demarcated by LactC2-RFP are shown. In the middle panels replicating S. lugdunensis that
are devoid of LactC2-RFP are shown, and in the bottom, replicating bacteria are Lact-C2negative in the same cell with a Lact-C2-positive bead is shown. These images are
representative of observations made from four independent experiments. Scale bars equal
10 µm. In (D) images shown are wide-field micrographs that were subjected to
deconvolution; the bottom panel is a Z projection of 5 slices through the middle of the
macrophage. The white asterisks in the bottom panels mark the location of the IgG coated
bead. In (E) representative transmission electron micrographs of show intact phagosomes
containing S. lugdunensis in control macrophages (top panel) and discontinuous
phagosomes in the inhibitor treated macrophages (bottom panel) at 24 h post-infection.
Black arrows point to intact phagosomal membrane and red arrows point to areas of the
phagosome where electron dense membrane is compromised. Scale bars equal 4.1 µm.
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Figure 10. S. lugdunensis N920143 is able to escape phagosomal containment despite
a lack of toxin production. RAW 264.7 macrophages were infected with the nonhemolytic strain of S. lugdunensis (N920143) expressing GFP that were labeled with
eFluor at an MOI of 10. 24 hours post-infection infected cells that were treated with ConA,
DPI and protease inhibitors together were fixed and immunostained for the LAMP-1
protein. It was observed that eFluor positive bacteria remain LAMP-1 positive (upper
panels), but eFluor-negative bacteria become LAMP-1 negative (lower panels), matching
what was previously observed with S. lugdunensis strain HKU09-01. Images are
representative of observations from 3 independent experiments. Scale bar=10um, dotted
line indicates the macrophages plasma membrane

3.9 Despite escaping the phagosome replicating S. lugdunensis do not intoxicate the
host cell.
Given that phagosomal disruption and release of bacteria into the cytosol is known
to induce the process of inflammatory cell death known as pyroptosis (130) and that
replicating S. lugdunensis appear to escape phagosomal containment, I next sought to
determine whether or not the intracellularly replicating S. lugdunensis were toxic to the
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host cells. To this end, macrophages, with and without S. lugdunensis infection, were
treated with vehicle control or a cocktail of inhibitors (ConA, DPI and protease inhibitors)
that enabled S. lugdunensis growth and were stained with the viability dye propidium
iodide (PI) to assess integrity of the macrophage plasmalemma and phagocyte viability
(Figure 11A and B). In these experiments, macrophages were rarely PI-positive (3 to 6%),
irrespective of pharmacological treatment or infection with S. lugdunensis (Figure 11A and
B). Given infected macrophages remain refractory to PI, I next determined whether
infected macrophages are capable of phagocytosis. As before, macrophages were treated
with and without inhibitors and in the presence and absence of S. lugdunensis infection. 24
hours post-infection, IgG opsonized latex beads were incubated with control and infected
macrophages. It was observed that both control and infected macrophages, including those
containing replicating bacteria, retained their ability to ingest IgG-opsonized phagocytic
targets (Figure 11C and D and data not shown). These data indicated that in RAW
macrophages S. lugdunensis even when replicating, presumably in the host cell cytoplasm,
do not compromise basic macrophage functions.
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Figure 11. Intracellular replication of S. lugdunensis does not affect macrophage
viability or function. RAW macrophages were infected with GFP expressing S.
lugdunensis that were co-labeled with eFluor670 at an MOI of 10. In (A) infected
macrophages with (upper) and without inhibitor treatments (lower) were stained with 1 µM
Propidium Iodide (PI) 24 hours post infection; arrows indicate S. lugdunensis that reside
within PI-negative macrophages. The percent of PI positive cells for each sample was
quantified at 24 hours in (B) showing no change in the rate of macrophage death for the
experimental treatments compared to uninfected controls. In (C) macrophages were
infected with GFP and eFluor labeled S. lugdunensis with (right) and without inhibitor
treatment (left) for 24 hours after which IgG coated beads were added for 30 minutes. In
(D) the phagocytic index of infected and uninfected cells was enumerated. Infection with
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replicating S. lugdunensis had no effect on the ability of the macrophages to undergo
phagocytosis. Images shown are representative wide-field micrographs and all results are
obtained from 3 independent experiments. In (B) and (D) n.s. indicates the means are not
significantly different. Scale bars equal 10 µm.

3.10 S. aureus supernatant is toxic to macrophages and can permit the growth of
intracellular S. lugdunensis.
The next goal was to identify more physiologically relevant settings in which S.
lugdunensis could be coaxed into growth within macrophages. It is well known that S.
lugdunensis and S. aureus can both reside on human skin and engage in complex
interactions, and although rare co-infections with S. lugdunensis and S. aureus have been
reported to occur (72). To begin to investigate the bacterial interactions between these
species, S. aureus USA300, and S. lugdunensis N920143 and HKU09-01 were streaked
toward a cross streak of b-toxin producing S. aureus RN4220 on blood agar (Figure 12A).
S. aureus USA300 is hemolytic and the toxins made by USA300 can synergize with btoxin produced by S. aureus RN4220 (Figure 12A). In contrast, S. lugdunensis N920143 is
non-hemolytic even when in proximity S. aureus RN4220 (Figure 12A). Remarkably, S.
lugdunensis HKU09-01 which demonstrates a-hemolysis, potently causes red cell lysis
when growing in proximity to b-toxin producing RN4220 (Figure 12A). When culture
supernatants from these strains were added to RAW macrophages it was evident that S.
aureus USA300 is highly toxic as indicated by PI staining of macrophages (Figure 12B
and C). In contrast, supernatant from S. lugdunensis HKU09-01 and N920134 were nontoxic, regardless of toxin production, resulting in macrophage PI staining that was
indistinguishable from a TSB control (Figure 12B and C). Due to its cytolytic ability,
supernatant from S. aureus USA300 was added to macrophages 1.5 h after infection with
S. lugdunensis HKU09-01 as a mock co-infection. Treatment with USA300 supernatant
led to roughly a ~100-fold increase in S. lugdunensis compared to control treated cells by
24 h post-infection (Figure 12D). These data reveal that toxins produced by extracellular
S. aureus during a co-infection could exacerbate S. lugdunensis infection by intoxicating
infected macrophages and allowing release of phagocytosed S. lugdunensis.
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Figure 12. Intracellular S. lugdunensis can proliferate upon macrophage intoxication
by S. aureus supernatant. In (A) the hemolytic activity and b-toxin synergy for S. aureus
USA300, S. lugdunensis HKU09-01 and S. lugdunensis N920134 cultured on TSA with
5% (v/v) sheep blood agar is shown. Synergy is evident for USA300 and HKU09-01 in
proximity to S. aureus RN4220. In (B) the effect of culture supernatants, derived from the
strains in (A), on macrophage viability is shown. The graph depicts the average number of
propidium iodide (i.e. necrotic cells) positive cell remaining adhered to coverslips for
image analysis. The data presented are the mean ± S.D of three independent experiments.
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PI staining was performed 2 hr after the addition of 10% (v/v) culture supernatant or the
TSB control. # Indicates a large fraction of macrophages had detached from the coverslip
and were not quantifiable by microscopy indicating many more macrophages had become
intoxicated by the S. aureus supernatant. This is also evident by the lower apparent cell
density for the USA300 supernatant treated condition in the representative images
presented in (C). In (D) the effect of S. aureus USA300 supernatant on S. lugdunensis
growth from infected macrophages is shown.

Input represents the number of S.

lugdunensis HKU09-01 bacteria residing within macrophages and were protected from
gentamicin at 1.5 h post-infection. After gentamicin treatment S. lugdunensis infected
macrophages were treated with either TSB control (10% v/v) or S. aureus USA300 derived
supernatant (10% v/v) for 22.5h. At 24 h the bacterial burden for each was determined and
represents the growth of bacteria inside and outside macrophages as the bacteria are
liberated from dying macrophages. (*** denotes P<0.001 and statistical significance was
established by a student t-test).

3.11 The growth of both S. lugdunensis and S. aureus is enhanced during in vitro coinfections.
To determine whether S. lugdunensis passively survives or remains virulent within
macrophages I next performed co-infection experiments where I monitored the impact of
a co-infection on the replication of intracellular S. lugdunensis and S. aureus. For these coinfections macrophages were first infected with S. lugdunensis, then the S. lugdunensiscontaining macrophages were infected with S. aureus USA300 12 hours after phagocytosis
of S. lugdunensis (Figure 13). As controls, macrophages with S. lugdunensis were left
unexposed to S. aureus USA300 or cells were infected with S. aureus in the absence of S.
lugdunensis. Previously our lab has demonstrated that S. aureus exhibits significantly
delayed growth within macrophages, with replication becoming evident at ~10-12 hours
post infection (42). However, analysis of co-infections revealed that the intracellular
growth of S. aureus is accelerated when macrophages have already been infected with S.
lugdunensis as compared to S. aureus infection alone (Figure 13A, C and E). Indeed, by 6
hours post-infection when both bacterial species are present S. aureus proliferation is
evident within ~5% of infected macrophages, whereas replication of S. aureus was not
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evident at the same time point in the absence of intracellular S. lugdunensis (Fig 13A and
E). Also consistent with our previous observations S. lugdunensis alone failed to replicate
within macrophages (Figure 13B and D) while, in contrast, with S. aureus co-infection,
replicating S. lugdunensis can be observed within ~ 3-4% of S. lugdunensis infected
macrophages after only 6 hours in the absence of pharmacologic intervention (Figure 13B
and F). These data indicate that although most intracellular bacteria do not replicate, S.
lugdunensis are not entirely passive after being phagocytosed by macrophages and in the
presence of S. aureus both bacterial species can exhibit enhanced growth.
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Figure 13. Co-infection of macrophages with S. lugdunensis and S. aureus augments
the intracellular replication of both species.

Macrophages were infected with S.

lugdunensis expressing mCherry or S. aureus expressing GFP alone or were sequentially
added in a co-infection described in the methods. (A) and (B) show that the percentage of
macrophages containing replicating S. aureus USA300 (A) or S. lugdunensis HKU09-01
(B) is significantly increased during co-infection compared each species alone. Replication
was assessed by fluorescence proliferation assay and bacterial growth was analyzed 6 h
after the addition of S. aureus. In (A) and (B) the data are the mean ± standard deviation of
three independent experiments. Statistical significance was determined by students t-test
where * indicates P<0.05 and ** indicates p<0.01. Representative images for each of the
infections are shown in C-F in order; (C) S. aureus mono-infection, (D) S. lugdunensis
mono-infection, (E) and (F) both show a coinfection demonstrating replicating S. aureus
and S. lugdunensis respectively. Inset panels are magnified images of the boxed regions
and scale bars are equal to 10μm.

3.12 S. lugdunensis infection significantly increases S. aureus burden in the livers of
mice.
Following the observation that S. lugdunensis can indeed survive within Kupffer
cells for extended periods, I next sought to determine whether prior S. lugdunensis infection
could enhance S. aureus infection in the liver as would be inferred from our in vitro coinfection data (Fig. 13A and E). To this end, S. lugdunensis HKU09-01 was injected into
mice via the tail vein 16h prior to S. aureus USA300 and, at 8 h post-infection with S.
aureus (24 h after S. lugdunensis), the livers of infected animals were removed, and the
bacterial burden was determined. These infections were compared to those of mice infected
with either S. lugdunensis or S. aureus alone. It is worth noting that when S. lugdunensis
alone was used to infect the mice, bacteria could still be recovered 24 hours post infection,
consistent with what was previously observed with intravital microscopy (Figure 3).
Moreover, it was discovered that co-infection with S. lugdunensis HKU09-01 and S. aureus
USA300 resulted in a significantly higher burden for S. aureus in the livers of mice,
compared to those infected with an equal number of S. aureus alone (Figure 14A).
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Considering, S. lugdunensis HKU09-01 is hemolytic and shows synergy with b-toxin
producing S. aureus (see Fig. 12A) I also tested whether the non-hemolytic S. lugdunensis
N920143 would produce a similar response during murine infections. Once again, prior
infection with the non-hemolytic S. lugdunensis strain N920143 augmented S. aureus
infection as compared to S. aureus infection alone (Fig. 14B). To begin to understand how
S. lugdunensis might enhance S. aureus growth I performed similar co-infection
experiments where mice were injected with either live or dead S. lugdunensis at 10-fold
dilutions of cell densities, starting at 5x107, prior to injection of S. aureus. Injection of the
maximum dose of live or dead S. lugdunensis, into the tail vein, prior to S. aureus infection
significantly increased the burden of S. aureus in the liver as compared to S. aureus alone
(Figure 14C). In contrast, when 10-fold fewer live or dead S. lugdunensis are injected prior
to S. aureus infection, only live S. lugdunensis at this density augmented subsequent S.
aureus growth in the liver (Figure 14C). Finally, injection of 5x105 or fewer live or dead
S. lugdunensis fails to elicit this effect and the burden of S. aureus in the liver is not
different from S. aureus alone (Figure 14C). Taken together, these data are consistent with
the notion that S. lugdunensis is not benign and that a reservoir of S. lugdunensis in Kupffer
cells remain virulent for significant time after being phagocytosed and can exacerbate
infection by S. aureus in vivo.
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Figure 14. S. lugdunensis bacteria enhance S. aureus infection of the murine liver. In
(A) The bacterial burden from the livers of mice infected with either the hemolytic S.
lugdunensis HKU09-01 or S. aureus USA300 alone, or S. lugdunensis HKU09-01 and S.
aureus USA300 together are shown. The counts from co-infected livers are for S. aureus
CFUs only, but are significantly increased in the co-infected livers, compared to those
infected with S. aureus alone. The data are presented as Log10 CFU/mL with each symbol
representing a single animal. The horizontal bar represents the mean Log10 CFU/mL value
with the stander error shown. Burdens were determined at 8 h post-S. aureus infection
which was injected 16 h post-S. lugdunensis infection. In (B) the burden of S. aureus
coming from livers containing the non-hemolytic S. lugdunensis N920143 and S. aureus
USA300 or just S. aureus USA300 alone. As in (A) the counts for co-infected livers are of
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S. aureus only and are increased compared to the livers with only S. aureus. The data are
presented as Log10 CFU/mL and each symbol represents one animal. Horizontal bar
represents the mean Log10 value with the standard error and the burdens were determined
at 8 h post-S. aureus infection. ***p<0.0001, students t-test. In (C) similar infections were
performed as in (A) and (B) however live or dead S. lugdunensis HKU09-01 were injected
via tail vein 16 h prior to S. aureus infection. 1x represents undiluted S. lugdunensis
injected (5x107 bacteria) and 0.1x, 0.01x and 0.001x represent sequential 10-fold dilutions
of live or dead S. lugdunensis bacteria that were injected into mice. The addition of the
maximum or 10-fold diluted dose of live S. lugdunensis was sufficient to increase the S.
aureus burden, while only the maximum dose of dead S. lugdunensis led to an increase in
S. aureus. Each symbol represents a single animal. The data presented as described for (A)
and (B) above. Statistical significance was determined by one-way ANOVA, with a
Bonferroni post hoc test where ** P<0.01 and **** p<0.0001.
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CHAPTER 4 – DISCUSSION AND FUTURE DIRECTIONS
S. lugdunensis is part of the normal human skin flora (69,72), that has emerged as
an opportunistic pathogen with the capability to cause severe disease. It has become clear
that S. lugdunensis is unique among CoNS in its ability to cause infection (70,131,132).
Along with the ability to cause severe infections, antibiotic resistant strains of S.
lugdunensis have begun to be found around the world (75,77,91,92). Despite the emergence
of this species as a significant human pathogen there has been relatively little research
regarding the pathogenic mechanisms of this species and few virulence factors have been
identified (82,88,133,134). This study demonstrates that acetylation of the peptidoglycan
by oatA contributes to the ability of S. lugdunensis to evade killing by host macrophages
both in vitro and in vivo (67). Within macrophages S. lugdunensis was found to inhabit the
mature phagolysosome for extended periods of time although was unable to replicate.
Notably, S. lugdunensis could be coaxed to replicate by inhibiting the v-ATPase or
lysosomal proteases and following replicating S. lugdunensis was found to escape
phagolysosomal containment (67). Furthermore, it was found that S. lugdunensis is able to
potentiate the virulence of S. aureus in both in vitro and in vivo coinfection models.
S. lugdunensis clearly does not possess the same arsenal of virulence factors as
other successful pathogens such as S. aureus, or Salmonella enterica serovar Typhimurium
(42,135), but still manages to cause serious infections. Moreover, the ability of S.
lugdunensis to persist within macrophages for extended periods of time is a key aspect of
what defines a pathogen according to “the macrophages paradox” (136). It is important to
recognize the ability of macrophages to restrict the growth of S. lugdunensis as an
antibacterial phenotype, although the inability to eliminate S. lugdunensis indicates that the
bacteria are able, in some capacity, to circumvent antimicrobial aspects of the
phagolysosome. This is supported by the observation that inactivation of oatA renders S.
lugdunensis more susceptible to macrophage killing in vitro and in vivo. Interestingly,
oatA-deficient bacteria are not entirely eradicated, indicating that other factors must also
contribute to intracellular survival of S. lugdunensis. Intracellular persistence could
possibly allow S. lugdunensis to utilize host macrophages as a bacterial reservoir allowing
S. lugdunensis to avoid immune detection. If the integrity of S. lugdunensis-containing
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macrophages were to become compromised by some external factor viable S. lugdunensis
could conceivably be released seeding secondary infections. In support of this notion this
report has shown that toxins produced by S. aureus can intoxicate S. lugdunensiscontaining macrophages promoting the outgrowth of S. lugdunensis. Furthermore, it was
demonstrated that S. lugdunensis, just like S. aureus, is rapidly taken up by Kupffer cells
(68) and survives within the murine liver for at least 24 hours, highlighting the importance
of intracellular survival in the context of systemic infections. This finding also speaks to
the potential for co-infections with S. lugdunensis and S. aureus, as both species are able
to cause invasive infections, and inhabit the same niche during systemic infections in
mouse models.
On occasions when S. lugdunensis is able to infect a host, it tends to result in highly
virulent infections that are clinically similar to S. aureus, although S. aureus is a much
more common cause of infections. Notably, these species inhabit the same intracellular
niche, but the inability of S. lugdunensis to replicate within macrophages represents a
significant difference in the pathogenesis of these species. It is possible that the lower rate
of infections caused by S. lugdunensis represents an inability to effectively gather iron
contributing to a lack of intracellular growth. As reviewed previously, S. lugdunensis
encodes the HtsA and SirA receptors for utilization of the SA and SB siderophores
produced by S. aureus (95), but is incapable of synthesizing these siderophores on its own.
This suggests that S. lugdunensis would exist in an iron limited state within the host, as
humans have evolved effective mechanisms for sequestering iron away from microbes
(32). Co-infection with S. aureus could potentially lead to enhanced growth of S.
lugdunensis by means of xenosiderophore usage, as co-culture experiments have
demonstrated the growth promotion of S. lugdunensis by S. aureus when iron was limited
(95). The observation that S. lugdunensis can be permitted to replicate intracellularly by
inhibiting the v-ATPase or lysosomal proteases serves to show that iron-limitation is
clearly not the sole factor restricting the growth of S. lugdunensis. However, S. lugdunensis
may still be limited by its access to available iron as replicating S. lugdunensis remained
confined to the host cell for 24 hours, whereas S. aureus are able to grow to high enough
numbers to kill and emerge from the macrophage (42). The various iron acquisition
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mechanisms employed by S. lugdunensis remain an area of active investigation and the
role iron plays in the pathogenesis of this species remains to be seen.
The fact that treatment of macrophages with ConA, Pepstatin A and antipain, or
PIK-III to inhibit, acidification, proteases or Vps34 implies that a yet to be identified
protease that is active in the phagolysosome is responsible for preventing intracellular
replication by S. lugdunensis. Presumably ConA permits intracellular replication by
indirectly inhibiting protease activity in the phagosome. Many phagosomal proteases
function optimally at acidic pH (31,137), so ConA treatment would hinder the activity of
several proteases, including those inhibited by Pepstatin A and antipain, suggesting a
protease is the true restrictive factor. Furthermore, treatment of either RAW or primary
human macrophages with PIK-III allowed for replication by S. lugdunensis. By blocking
Vps34 activity PIK-III functions to arrest phagosome maturation preventing the formation
of the phagolysosome (38). Because S. lugdunensis is able to replicate in the arrested
phagosome, the specific factor responsible for growth restriction must only be active in the
mature phagolysosome. Unfortunately, treatment of S. lugdunensis-containing primary
human cells with ConA in addition to DPI, Pepstatin A and antipain, did not permit
intracellular replication. This serves to highlight the functional differences between RAW
and primary human macrophages and underscores the importance of replicating results in
primary cells for infection models.
In contrast to other pathogens like M. tuberculosis or Legionella pneumophila
(37,138), this work has shown that S. lugdunensis is unable to perturb phagosome
maturation, and instead resides within mature phagolysosomes similar to S. aureus (42).
However, when S. lugdunensis is coaxed to replicate by inhibiting phagosomal effectors
the bacteria are able to escape phagosomal containment, reminiscent of L. monocytogenes
(39). Dissolution of the phagosomal membrane should allow increased access to the host
cell cytoplasm and the nutrients that are actively sequestered away from the phagosome,
which should support bacterial replication. Conversely, it would be expected that the host
cell could detect and respond to the cytosolic bacteria leading to the induction of
inflammatory cell death known as pyroptosis as a way to limit cytosolic bacteria (127).
However, macrophages containing replicating S. lugdunensis at 24 hours post-infection
appear healthy and showed no signs of pyroptosis. Furthermore, these macrophages
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showed no obvious functional impairment as they retained the ability to phagocytose equal
to uninfected cell. It is tantalizing to speculate about the ability of intracellular S.
lugdunensis to actively interfere with inflammasome activation in order to sustain its
intracellular survival. This possibility is not unprecedented as other bacterial pathogens are
able to either avoid detection by the host cell or actively inhibit inflammasome formation
(139). Unfortunately, it remains unknown how S. lugdunensis is able to both escape the
phagosome and avoid the induction of pyroptosis.
While S. lugdunensis is an important pathogen with the ability to cause severe
infections on its own, it has now been demonstrated that S. lugdunensis has the ability to
enhance the growth of S. aureus during a co-infection both in vitro and in vivo. During the
in vitro co-infections it was found that both S. lugdunensis and S. aureus were able to
benefit from the presence of each other. It was observed that S. lugdunensis was able to
initiate intracellular replication, which was absent in mono infections, and S. aureus was
able to begin replicating much quicker in co-infected cells compared to mono-infected cells
(42,67). Importantly the beneficial effect conferred to S. aureus, by S. lugdunensis was
recapitulated in vivo. Based on the results obtained from the in vitro experiments it would
also be expected that S. lugdunensis may be able to better replicate within the co-infected
livers leading to an increase in CFU. Unfortunately, during the in vivo co-infections only
the CFUs for S. aureus were able to be counted. The reason for this is that when plating
the lysate from the mixed infections S. aureus is able to grow much faster on TSA plates
than S. lugdunensis. This means when colonies became visible for counting, only S. aureus
was visible and by the time S. lugdunensis colonies would have grown they would have
been overshadowed by the growth of S aureus. In order to determine the number of S.
lugdunensis CFUs in our co-infection samples, an antibiotic resistance cassette could be
knocked in to the chromosome of S. lugdunensis. Then by plating the mixed infection
lysates side by side on TSA plates and TSA plates with antibiotics, the S. lugdunensis
colonies would be selected for, allowing for CFU determination. This will allow us to
determine if these two species offer each other a benefit during in vivo infections, similar
to what was observed in vitro, or if S. aureus is the sole beneficiary of this interaction.
Regardless the ability of S. lugdunensis to potentiate the virulence of S. aureus is an
interesting phenotype that is the polar opposite of the interactions of these species during
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colonization (96). This serves to highlight the role that environmental context plays in
shaping the interactions between different bacterial species. Furthermore, the ability to
enhance the virulence of a pathogen such as S. aureus is a significant finding and is
expected to generate great interest into the outcomes of co-infections between these as well
as other important pathogenic species.
While the observations in this thesis are expected to generate significant interest,
there is still a lot of work to be completed. It was demonstrated that oatA contributes to
intracellular survival but there are clearly other factors that remain to be identified that
permit low level persistence in the absence of oatA. Additionally, the ability of S.
lugdunensis to escape phagosomal containment is a significant difference from S. aureus,
and likely requires the action of a yet to be identified virulence factor. It is possible that the
factor allowing for phagosomal escape is a pore forming toxin or phospholipase of some
sort, similar to the machinery employed by L. monocytogenes for phagosomal escape (39–
41), although further work is required to characterize the escape mechanism employed by
S. lugdunensis. Lastly, it is not known whether S. lugdunensis confers a growth benefit to
S. aureus by directly interacting with S. aureus, or if S. lugdunensis is able to affect the
macrophages making them more hospitable towards S. aureus during co-infection. These
questions remain areas of active investigation within the lab.
In summary S. lugdunensis is an important emerging CoNS species that stands out
for its ability to cause severe infections. This work has shown that S. lugdunensis is not
killed by macrophages but rather is able to persist within the mature phagolysosome for
extended periods of time without intoxicating the host cell. The ability of this species to
survive intracellularly without killing the host cell suggests that this bacterium could be
using host phagocytes as a “trojan horse” allowing them to evade detection by the immune
system. This evasion could then contribute to the dissemination of infection if S.
lugdunensis were to be released from the macrophages due to some external factors, such
as a co-infection. In support of this S. lugdunensis was able to replicate when co-infecting
with S. aureus and the addition of S. aureus’ toxins to S. lugdunensis containing cells
resulted in the release and growth of S lugdunensis. Together this work supports the notion
that S. lugdunensis could indeed utilize host macrophages as a bacterial reservoir.
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